BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 015800
(400 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 178 bits (451), Expect = 5e-45, Method: Compositional matrix adjust.
Identities = 87/127 (68%), Positives = 102/127 (80%)
Query: 262 RQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ 321
R++ Q FFDV + EV LG LKRF +ELQ A+ NFS+KN++G+GGFG VYKG L
Sbjct: 1 RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 322 DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381
DGT+VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NG
Sbjct: 61 DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 382 SVASRLK 388
SVAS L+
Sbjct: 121 SVASCLR 127
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 171 bits (434), Expect = 6e-43, Method: Compositional matrix adjust.
Identities = 83/119 (69%), Positives = 96/119 (80%)
Query: 270 FFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVK 329
FFDV + EV LG LKRF +ELQ A+ NF +KN++G+GGFG VYKG L DG +VAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK 60
Query: 330 RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
RLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS L+
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 119
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 46/103 (44%), Positives = 64/103 (62%), Gaps = 1/103 (0%)
Query: 288 RFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEV 347
R +L+ AT+NF K L+G G FG VYKG L+DG VA+KR + + G +F+TE+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEI 86
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGS 390
E +S H +L+ LIGFC E +L+Y YM NG++ L GS
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 46/103 (44%), Positives = 64/103 (62%), Gaps = 1/103 (0%)
Query: 288 RFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEV 347
R +L+ AT+NF K L+G G FG VYKG L+DG VA+KR + + G +F+TE+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEI 86
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGS 390
E +S H +L+ LIGFC E +L+Y YM NG++ L GS
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 48/122 (39%), Positives = 67/122 (54%), Gaps = 10/122 (8%)
Query: 275 EQRREEVCLGNLKRFHFKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAV 328
E + EV F F EL++ T+NF + N +G+GGFG VYKGY+ + T VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 329 KRLKDGNAIGGE---IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS 385
K+L I E QF E+++++ H NL+ L+GF + LVY YM NGS+
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 386 RL 387
RL
Sbjct: 120 RL 121
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 48/122 (39%), Positives = 67/122 (54%), Gaps = 10/122 (8%)
Query: 275 EQRREEVCLGNLKRFHFKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAV 328
E + EV F F EL++ T+NF + N +G+GGFG VYKGY+ + T VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 329 KRLKDGNAIGGE---IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS 385
K+L I E QF E+++++ H NL+ L+GF + LVY YM NGS+
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 386 RL 387
RL
Sbjct: 120 RL 121
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 47/112 (41%), Positives = 65/112 (58%), Gaps = 13/112 (11%)
Query: 288 RFH---FKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG 338
RFH F EL++ T+NF + N +G+GGFG VYKGY+ + T VAVK+L I
Sbjct: 5 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 63
Query: 339 GE---IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL 387
E QF E+++++ H NL+ L+GF + LVY YM NGS+ RL
Sbjct: 64 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 115
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 46/112 (41%), Positives = 62/112 (55%), Gaps = 13/112 (11%)
Query: 288 RFH---FKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG 338
RFH F EL++ T+NF + N G+GGFG VYKGY+ + T VAVK+L I
Sbjct: 2 RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 60
Query: 339 GE---IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL 387
E QF E+++ + H NL+ L+GF + LVY Y NGS+ RL
Sbjct: 61 TEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL 112
>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1
Ectodomain
pdb|3RJ0|A Chain A, Plant Steroid Receptor Bri1 Ectodomain In Complex With
Brassinolide
Length = 772
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 36/78 (46%), Positives = 50/78 (64%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 166
+SG+IP EIG + L L+L +N +G IP V L L L L++N L G IP ++S +
Sbjct: 641 LSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL 700
Query: 167 SQLAFLDLSYNNLSGPVP 184
+ L +DLS NNLSGP+P
Sbjct: 701 TMLTEIDLSNNNLSGPIP 718
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 43/81 (53%), Positives = 52/81 (64%), Gaps = 3/81 (3%)
Query: 108 SGHIPTEIGKLS-KLLTLDLSNNFFTGPIPSTVSH--LETLQYLRLNNNSLTGAIPPSLS 164
SG +P + LS LLTLDLS+N F+GPI + TLQ L L NN TG IPP+LS
Sbjct: 353 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 412
Query: 165 NMSQLAFLDLSYNNLSGPVPS 185
N S+L L LS+N LSG +PS
Sbjct: 413 NCSELVSLHLSFNYLSGTIPS 433
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 40/103 (38%), Positives = 55/103 (53%)
Query: 83 LSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 142
LSGT+ SS+G + G IP E+ + L TL L N TG IPS +S+
Sbjct: 427 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 486
Query: 143 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
L ++ L+NN LTG IP + + LA L LS N+ SG +P+
Sbjct: 487 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 529
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 36/88 (40%), Positives = 53/88 (60%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 166
+SG IP+ +G LSKL L L N G IP + +++TL+ L L+ N LTG IP LSN
Sbjct: 427 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 486
Query: 167 SQLAFLDLSYNNLSGPVPSFHAKTFNIT 194
+ L ++ LS N L+G +P + + N+
Sbjct: 487 TNLNWISLSNNRLTGEIPKWIGRLENLA 514
Score = 58.2 bits (139), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 31/79 (39%), Positives = 47/79 (59%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 166
++G IP+ + + L + LSNN TG IP + LE L L+L+NNS +G IP L +
Sbjct: 475 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 534
Query: 167 SQLAFLDLSYNNLSGPVPS 185
L +LDL+ N +G +P+
Sbjct: 535 RSLIWLDLNTNLFNGTIPA 553
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 31/78 (39%), Positives = 47/78 (60%)
Query: 108 SGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMS 167
+G IP + S+L++L LS N+ +G IPS++ L L+ L+L N L G IP L +
Sbjct: 404 TGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK 463
Query: 168 QLAFLDLSYNNLSGPVPS 185
L L L +N+L+G +PS
Sbjct: 464 TLETLILDFNDLTGEIPS 481
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 32/78 (41%), Positives = 40/78 (51%)
Query: 83 LSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 142
LSG + IG ISG IP E+G L L LDLS+N G IP +S L
Sbjct: 641 LSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL 700
Query: 143 ETLQYLRLNNNSLTGAIP 160
L + L+NN+L+G IP
Sbjct: 701 TMLTEIDLSNNNLSGPIP 718
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/81 (43%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 166
+SG I ++L L++S+N F GPIP L++LQYL L N TG IP LS
Sbjct: 232 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGA 289
Query: 167 -SQLAFLDLSYNNLSGPVPSF 186
L LDLS N+ G VP F
Sbjct: 290 CDTLTGLDLSGNHFYGAVPPF 310
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 24/57 (42%), Positives = 34/57 (59%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL 163
++G IP IG+L L L LSNN F+G IP+ + +L +L LN N G IP ++
Sbjct: 499 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 555
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 39/76 (51%)
Query: 109 GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQ 168
GH ++ LD+S N +G IP + + L L L +N ++G+IP + ++
Sbjct: 619 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 678
Query: 169 LAFLDLSYNNLSGPVP 184
L LDLS N L G +P
Sbjct: 679 LNILDLSSNKLDGRIP 694
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 45/157 (28%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 32 EVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCSDGLVTGLGAPSQNLSGTLSSSI 91
E+ L+ KD L D ++L +W N +PC++ VTC D VT + S+ L+ S++
Sbjct: 10 EIHQLISFKDVLPD-KNLLPDWSSNK-NPCTFDGVTCRDDKVTSIDLSSKPLNVGF-SAV 66
Query: 92 GXXXXXXXXXXXXXXISGHIPTEIGKL---SKLLTLDLSNNFFTGPIPSTVS--HLETLQ 146
+ HI + + L +LDLS N +GP+ + S L+
Sbjct: 67 SSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLK 126
Query: 147 YLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYNNLSG 181
+L +++N+L G + L ++ L LDLS N++SG
Sbjct: 127 FLNVSSNTLDFPGKVSGGLK-LNSLEVLDLSANSISG 162
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 166
ISG + ++ + L LD+S+N F+ IP + LQ+L ++ N L+G ++S
Sbjct: 187 ISGDV--DVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTC 243
Query: 167 SQLAFLDLSYNNLSGPVPSFHAKTF 191
++L L++S N GP+P K+
Sbjct: 244 TELKLLNISSNQFVGPIPPLPLKSL 268
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 34/148 (22%), Positives = 53/148 (35%), Gaps = 46/148 (31%)
Query: 83 LSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV--- 139
L+G + IG SG+IP E+G L+ LDL+ N F G IP+ +
Sbjct: 499 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 558
Query: 140 ------SHLETLQYLRLNNNSLT------------------------------------- 156
+ + +Y+ + N+ +
Sbjct: 559 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 618
Query: 157 GAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
G P+ N + FLD+SYN LSG +P
Sbjct: 619 GHTSPTFDNNGSMMFLDMSYNMLSGYIP 646
Score = 36.6 bits (83), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 2/78 (2%)
Query: 81 QNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 140
++SG++ +G + G IP + L+ L +DLSNN +GPIP +
Sbjct: 663 NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE-MG 721
Query: 141 HLETLQYLR-LNNNSLTG 157
ET + LNN L G
Sbjct: 722 QFETFPPAKFLNNPGLCG 739
Score = 34.7 bits (78), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 18/71 (25%), Positives = 40/71 (56%)
Query: 114 EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLD 173
++ +LS ++++ + G T + ++ +L ++ N L+G IP + +M L L+
Sbjct: 600 QLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILN 659
Query: 174 LSYNNLSGPVP 184
L +N++SG +P
Sbjct: 660 LGHNDISGSIP 670
>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
pdb|3RGZ|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
Length = 768
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 36/78 (46%), Positives = 50/78 (64%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 166
+SG+IP EIG + L L+L +N +G IP V L L L L++N L G IP ++S +
Sbjct: 644 LSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL 703
Query: 167 SQLAFLDLSYNNLSGPVP 184
+ L +DLS NNLSGP+P
Sbjct: 704 TMLTEIDLSNNNLSGPIP 721
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 43/81 (53%), Positives = 52/81 (64%), Gaps = 3/81 (3%)
Query: 108 SGHIPTEIGKLS-KLLTLDLSNNFFTGPIPSTVSH--LETLQYLRLNNNSLTGAIPPSLS 164
SG +P + LS LLTLDLS+N F+GPI + TLQ L L NN TG IPP+LS
Sbjct: 356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415
Query: 165 NMSQLAFLDLSYNNLSGPVPS 185
N S+L L LS+N LSG +PS
Sbjct: 416 NCSELVSLHLSFNYLSGTIPS 436
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 40/103 (38%), Positives = 55/103 (53%)
Query: 83 LSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 142
LSGT+ SS+G + G IP E+ + L TL L N TG IPS +S+
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489
Query: 143 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
L ++ L+NN LTG IP + + LA L LS N+ SG +P+
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 36/88 (40%), Positives = 53/88 (60%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 166
+SG IP+ +G LSKL L L N G IP + +++TL+ L L+ N LTG IP LSN
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489
Query: 167 SQLAFLDLSYNNLSGPVPSFHAKTFNIT 194
+ L ++ LS N L+G +P + + N+
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLA 517
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 31/79 (39%), Positives = 47/79 (59%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 166
++G IP+ + + L + LSNN TG IP + LE L L+L+NNS +G IP L +
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 167 SQLAFLDLSYNNLSGPVPS 185
L +LDL+ N +G +P+
Sbjct: 538 RSLIWLDLNTNLFNGTIPA 556
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 31/78 (39%), Positives = 47/78 (60%)
Query: 108 SGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMS 167
+G IP + S+L++L LS N+ +G IPS++ L L+ L+L N L G IP L +
Sbjct: 407 TGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK 466
Query: 168 QLAFLDLSYNNLSGPVPS 185
L L L +N+L+G +PS
Sbjct: 467 TLETLILDFNDLTGEIPS 484
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 32/78 (41%), Positives = 40/78 (51%)
Query: 83 LSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 142
LSG + IG ISG IP E+G L L LDLS+N G IP +S L
Sbjct: 644 LSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL 703
Query: 143 ETLQYLRLNNNSLTGAIP 160
L + L+NN+L+G IP
Sbjct: 704 TMLTEIDLSNNNLSGPIP 721
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/81 (43%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 166
+SG I ++L L++S+N F GPIP L++LQYL L N TG IP LS
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 167 -SQLAFLDLSYNNLSGPVPSF 186
L LDLS N+ G VP F
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPF 313
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 24/57 (42%), Positives = 34/57 (59%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL 163
++G IP IG+L L L LSNN F+G IP+ + +L +L LN N G IP ++
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 558
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 39/76 (51%)
Query: 109 GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQ 168
GH ++ LD+S N +G IP + + L L L +N ++G+IP + ++
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 681
Query: 169 LAFLDLSYNNLSGPVP 184
L LDLS N L G +P
Sbjct: 682 LNILDLSSNKLDGRIP 697
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 45/157 (28%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 32 EVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCSDGLVTGLGAPSQNLSGTLSSSI 91
E+ L+ KD L D ++L +W N +PC++ VTC D VT + S+ L+ S++
Sbjct: 13 EIHQLISFKDVLPD-KNLLPDWSSNK-NPCTFDGVTCRDDKVTSIDLSSKPLNVGF-SAV 69
Query: 92 GXXXXXXXXXXXXXXISGHIPTEIGKL---SKLLTLDLSNNFFTGPIPSTVS--HLETLQ 146
+ HI + + L +LDLS N +GP+ + S L+
Sbjct: 70 SSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLK 129
Query: 147 YLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYNNLSG 181
+L +++N+L G + L ++ L LDLS N++SG
Sbjct: 130 FLNVSSNTLDFPGKVSGGLK-LNSLEVLDLSANSISG 165
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 166
ISG + ++ + L LD+S+N F+ IP + LQ+L ++ N L+G ++S
Sbjct: 190 ISGDV--DVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTC 246
Query: 167 SQLAFLDLSYNNLSGPVPSFHAKTF 191
++L L++S N GP+P K+
Sbjct: 247 TELKLLNISSNQFVGPIPPLPLKSL 271
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 34/148 (22%), Positives = 53/148 (35%), Gaps = 46/148 (31%)
Query: 83 LSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV--- 139
L+G + IG SG+IP E+G L+ LDL+ N F G IP+ +
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561
Query: 140 ------SHLETLQYLRLNNNSLT------------------------------------- 156
+ + +Y+ + N+ +
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621
Query: 157 GAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
G P+ N + FLD+SYN LSG +P
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIP 649
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 2/78 (2%)
Query: 81 QNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 140
++SG++ +G + G IP + L+ L +DLSNN +GPIP +
Sbjct: 666 NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE-MG 724
Query: 141 HLETLQYLR-LNNNSLTG 157
ET + LNN L G
Sbjct: 725 QFETFPPAKFLNNPGLCG 742
Score = 34.3 bits (77), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 18/71 (25%), Positives = 40/71 (56%)
Query: 114 EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLD 173
++ +LS ++++ + G T + ++ +L ++ N L+G IP + +M L L+
Sbjct: 603 QLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILN 662
Query: 174 LSYNNLSGPVP 184
L +N++SG +P
Sbjct: 663 LGHNDISGSIP 673
>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase
Inhibiting Protein), A Leucine Rich Repeat Protein
Involved In Plant Defense
Length = 313
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 111 IPTEIGKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQL 169
IP+ + L L L + N GPIP ++ L L YL + + +++GAIP LS + L
Sbjct: 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 170 AFLDLSYNNLSGPVPSFHAKTFNITGNSLIC--ATGAEEDCFGT 211
LD SYN LSG +P + N+ G + +GA D +G+
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 33/108 (30%), Positives = 54/108 (50%), Gaps = 1/108 (0%)
Query: 82 NLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
NL G + +I +SG IP + ++ L+TLD S N +G +P ++S
Sbjct: 88 NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQL-AFLDLSYNNLSGPVPSFHA 188
L L + + N ++GAIP S + S+L + +S N L+G +P A
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA 195
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 46/181 (25%), Positives = 66/181 (36%), Gaps = 55/181 (30%)
Query: 83 LSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLT-LDLSNNFFTGPIPSTVSH 141
LSGTL SI ISG IP G SKL T + +S N TG IP T ++
Sbjct: 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196
Query: 142 L----------------------------------------------ETLQYLRLNNNSL 155
L + L L L NN +
Sbjct: 197 LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRI 256
Query: 156 TGAIPPSLSNMSQLAFLDLSYNNLSGPVPS-FHAKTFNITGNSLICATGAEEDCFGTAPM 214
G +P L+ + L L++S+NNL G +P + + F+++ A C +P+
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY-------ANNKCLCGSPL 309
Query: 215 P 215
P
Sbjct: 310 P 310
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 33/121 (27%), Positives = 58/121 (47%), Gaps = 17/121 (14%)
Query: 274 NEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVA 327
N Q + C+ ++KR + K +G+G FG V+ QD +VA
Sbjct: 26 NPQYFSDACVHHIKR----------RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVA 75
Query: 328 VKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL 387
VK LK+ + + FQ E E++++ H++++R G C L+V+ YM +G + L
Sbjct: 76 VKALKEASESARQ-DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134
Query: 388 K 388
+
Sbjct: 135 R 135
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 31/115 (26%), Positives = 56/115 (48%), Gaps = 17/115 (14%)
Query: 280 EVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKD 333
+ C+ ++KR + K +G+G FG V+ QD +VAVK LK+
Sbjct: 9 DACVHHIKR----------RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE 58
Query: 334 GNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ + FQ E E++++ H++++R G C L+V+ YM +G + L+
Sbjct: 59 ASESARQ-DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLR 112
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 31/115 (26%), Positives = 56/115 (48%), Gaps = 17/115 (14%)
Query: 280 EVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKD 333
+ C+ ++KR + K +G+G FG V+ QD +VAVK LK+
Sbjct: 3 DACVHHIKR----------RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE 52
Query: 334 GNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ + FQ E E++++ H++++R G C L+V+ YM +G + L+
Sbjct: 53 ASESARQ-DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLR 106
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 47/100 (47%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G V L+
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ 105
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 47/100 (47%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G V L+
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ 105
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 51/113 (45%), Gaps = 3/113 (2%)
Query: 279 EEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN-- 335
EE K K+ Q A +F +GKG FGNVY Q ++A+K L
Sbjct: 14 EEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE 73
Query: 336 AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
G E Q + EVE+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 74 KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 126
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 51/113 (45%), Gaps = 3/113 (2%)
Query: 279 EEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN-- 335
EE K K+ Q A +F +GKG FGNVY Q ++A+K L
Sbjct: 14 EEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE 73
Query: 336 AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
G E Q + EVE+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 74 KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 126
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 51/113 (45%), Gaps = 3/113 (2%)
Query: 279 EEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN-- 335
EE K K+ Q A +F +GKG FGNVY Q ++A+K L
Sbjct: 5 EEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE 64
Query: 336 AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
G E Q + EVE+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 65 KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 117
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 1 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 61 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 105
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 105
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 3 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 63 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 102
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 4 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 64 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 4 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 64 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 101
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 101
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 4 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 64 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 4 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 64 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 101
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 3 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 63 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 102
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVE 348
K+ Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ S H N+LRL G+ T L+ Y G+V L+
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 105
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 48.1 bits (113), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 45/85 (52%), Gaps = 2/85 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY + VA+K +K+G+ E F E E++ H L++L G C+
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTIKEGSM--SEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 367 TTTERLLVYPYMSNGSVASRLKGSK 391
LV+ +M +G ++ L+ +
Sbjct: 93 EQAPICLVFEFMEHGCLSDYLRTQR 117
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 48.1 bits (113), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + +N S +VG G FG V G L+ VA+K LK G F E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++RL G + ++V YM NGS+ S L+ Q+ +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 48.1 bits (113), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + +N S +VG G FG V G L+ VA+K LK G F E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++RL G + ++V YM NGS+ S L+ Q+ +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 48.1 bits (113), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + +N S +VG G FG V G L+ VA+K LK G F E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++RL G + ++V YM NGS+ S L+ Q+ +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 48.1 bits (113), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + +N S +VG G FG V G L+ VA+K LK G F E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++RL G + ++V YM NGS+ S L+ Q+ +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 48.1 bits (113), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + +N S +VG G FG V G L+ VA+K LK G F E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++RL G + ++V YM NGS+ S L+ Q+ +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 48.1 bits (113), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + +N S +VG G FG V G L+ VA+K LK G F E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++RL G + ++V YM NGS+ S L+ Q+ +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + +N S +VG G FG V G L+ VA+K LK G F E
Sbjct: 38 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 95
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++RL G + ++V YM NGS+ S L+ Q+ +
Sbjct: 96 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 144
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + +N S +VG G FG V G L+ VA+K LK G F E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++RL G + ++V YM NGS+ S L+ Q+ +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + +N S +VG G FG V G L+ VA+K LK G F E
Sbjct: 11 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++RL G + ++V YM NGS+ S L+ Q+ +
Sbjct: 69 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 117
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + +N S +VG G FG V G L+ VA+K LK G F E
Sbjct: 28 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 85
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++RL G + ++V YM NGS+ S L+ Q+ +
Sbjct: 86 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 134
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 3/97 (3%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGYLQDGT-VVAVKRLKDGN--AIGGEIQFQTEVEMIS 351
Q A +F +GKG FGNVY ++ ++A+K L G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
H N+LRL G+ +T L+ Y G+V L+
Sbjct: 64 HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQ 100
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 351
Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE+ S
Sbjct: 3 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
H N+LRL G+ T L+ Y G+V L+
Sbjct: 63 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 99
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 351
Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE+ S
Sbjct: 7 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
H N+LRL G+ T L+ Y G+V L+
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 351
Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
H N+LRL G+ T L+ Y G+V L+
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 5/95 (5%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGT-----VVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
S + + ++G G FG VYKG L+ + VA+K LK G + F E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 354 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
H N++RL G +++ YM NG++ L+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR 138
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 351
Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
H N+LRL G+ T L+ Y G+V L+
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 351
Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
H N+LRL G+ T L+ Y G+V L+
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 351
Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
H N+LRL G+ T L+ Y G+V L+
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 351
Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
H N+LRL G+ T L+ Y G+V L+
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 351
Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
H N+LRL G+ T L+ Y G+V L+
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 100
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 351
Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE+ S
Sbjct: 7 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
H N+LRL G+ T L+ Y G+V L+
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 103
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 351
Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE+ S
Sbjct: 8 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
H N+LRL G+ T L+ Y G+V L+
Sbjct: 68 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 104
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS 351
Q A +F +GKG FGNVY Q ++A+K L G E Q + EVE+ S
Sbjct: 1 QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
H N+LRL G+ T L+ Y G+V L+
Sbjct: 61 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 97
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 183
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 35 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 95 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 123
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 34 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 94 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 122
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 300 NFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
N K +G+G FG V+ QD +VAVK LKD + F E E+++
Sbjct: 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNL 72
Query: 354 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKG 389
H ++++ G C+ ++V+ YM +G + L+
Sbjct: 73 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRA 108
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 54 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 142
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 55 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 143
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 41 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 129
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 124
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 124
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 34 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 94 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 122
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 124
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 124
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 37 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 97 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 125
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 35 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 95 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 123
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 119
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 37 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 97 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 125
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 44/85 (51%), Gaps = 2/85 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY + VA+K +++G E F E E++ H L++L G C+
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 367 TTTERLLVYPYMSNGSVASRLKGSK 391
LV+ +M +G ++ L+ +
Sbjct: 76 EQAPICLVFEFMEHGCLSDYLRTQR 100
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 44/85 (51%), Gaps = 2/85 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY + VA+K +++G E F E E++ H L++L G C+
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 367 TTTERLLVYPYMSNGSVASRLKGSK 391
LV+ +M +G ++ L+ +
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQR 95
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 44/85 (51%), Gaps = 2/85 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY + VA+K +++G E F E E++ H L++L G C+
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 367 TTTERLLVYPYMSNGSVASRLKGSK 391
LV+ +M +G ++ L+ +
Sbjct: 73 EQAPICLVFEFMEHGCLSDYLRTQR 97
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L DG + AVK L IG QF TE ++ H N+L
Sbjct: 28 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLK 388
L+G C+ + L+V PYM +G + + ++
Sbjct: 88 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 116
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 44/85 (51%), Gaps = 2/85 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY + VA+K +++G E F E E++ H L++L G C+
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 367 TTTERLLVYPYMSNGSVASRLKGSK 391
LV+ +M +G ++ L+ +
Sbjct: 73 EQAPICLVFEFMEHGCLSDYLRTQR 97
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 34/101 (33%), Positives = 46/101 (45%), Gaps = 3/101 (2%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMIS 351
Q +F +GKG FGNVY Q ++A+K L G E Q + EVE+ S
Sbjct: 8 QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR 392
H N+LRL G+ T L+ Y G+V L+ R
Sbjct: 68 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR 108
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 13/121 (10%)
Query: 289 FHFKELQSATSNFSSK---------NLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGN 335
F F++ A F+ + ++G G FG V G+L+ VA+K LK G
Sbjct: 14 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 336 AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYF 395
F +E ++ H N++ L G +T +++ +M NGS+ S L+ + Q+
Sbjct: 74 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 396 I 396
+
Sbjct: 134 V 134
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 34/101 (33%), Positives = 46/101 (45%), Gaps = 3/101 (2%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMIS 351
Q +F +GKG FGNVY Q ++A+K L G E Q + EVE+ S
Sbjct: 8 QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR 392
H N+LRL G+ T L+ Y G+V L+ R
Sbjct: 68 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR 108
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 84
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 85 VTQEPIYIITEYMENGSLVDFLK 107
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 85
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 86 VTQEPIYIITEYMENGSLVDFLK 108
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 82
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 83 VTQEPIYIITEYMENGSLVDFLK 105
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 86
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 87 VTQEPIYIITEYMENGSLVDFLK 109
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLK 99
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + +N S +VG G FG V G L+ VA+K LK G F E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++RL G + ++V M NGS+ S L+ Q+ +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV 146
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 78
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 79 VTQEPIYIITEYMENGSLVDFLK 101
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 82
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 83 VTQEPIYIITEYMENGSLVDFLK 105
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 81
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 82 VTQEPIYIITEYMENGSLVDFLK 104
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLK 99
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLK 99
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETR 129
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 77
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 78 VTQEPIYIITEYMENGSLVDFLK 100
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 307 VGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG V++ + T+VAVK LK+ + + FQ E +++ + N+++
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLK 388
L+G C L++ YM+ G + L+
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLR 142
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + +N S +VG G FG V G L+ VA+K LK G F E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++RL G + ++V M NGS+ S L+ Q+ +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV 146
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 2/85 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY + VA+K +++G E F E E++ H L++L G C+
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 367 TTTERLLVYPYMSNGSVASRLKGSK 391
LV +M +G ++ L+ +
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQR 98
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETR 143
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+G+G FG V+ G L+ D T+VAVK ++ + +F E ++ H N++RLIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 366 MTTTERLLVYPYMSNGSVASRLK 388
+V + G + L+
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR 204
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETR 129
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + +N S +VG G FG V G L+ VA+K LK G F E
Sbjct: 11 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++RL G + ++V M NGS+ S L+ Q+ +
Sbjct: 69 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV 117
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETR 129
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 72
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 73 VTQEPIYIITEYMENGSLVDFLK 95
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 71
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 72 VTQEPIYIITEYMENGSLVDFLK 94
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+G+G FG V+ G L+ D T+VAVK ++ + +F E ++ H N++RLIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 366 MTTTERLLVYPYMSNGSVASRLK 388
+V + G + L+
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR 204
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETR 143
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 4/97 (4%)
Query: 304 KNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
+ ++G G FG V G+L+ VA+K LK G F +E ++ H N++
Sbjct: 12 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
L G +T +++ +M NGS+ S L+ + Q+ +
Sbjct: 72 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 108
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 304 KNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
K +G+G FG V+ +D +VAVK LKD + FQ E E+++ H +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEH 78
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKG 389
+++ G C ++V+ YM +G + L+
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA 110
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETR 128
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 98 CIGVSLQSLPRFILLELMAGGDLKSFLRETR 128
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETR 135
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETR 145
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 90 CIGVSLQSLPRFILLELMAGGDLKSFLRETR 120
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETR 143
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 67
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ 111
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETR 169
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETR 155
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
IG + + R ++ M+ G + S L+ ++
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETR 146
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 67
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 111
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/96 (29%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
++ + K+ +G G FG VY+G + ++ VAVK LK+ E F E ++ H N
Sbjct: 11 TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 68
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
L++L+G C ++ +M+ G++ L+ RQ
Sbjct: 69 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 104
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 6 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 63
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 64 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ 107
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 67
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 111
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 55/97 (56%), Gaps = 10/97 (10%)
Query: 305 NLVGKGGFGNVYKGYL--QDGTV--VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLL 359
++G+G FG+V +G L +DGT VAVK +K N+ EI+ F +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 360 RLIGFCMTTTER-----LLVYPYMSNGSVASRLKGSK 391
RL+G C+ + + +++ P+M G + + L S+
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSR 136
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 66
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 110
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 26/97 (26%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 304 KNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
+ ++G G FG V +G L+ + VA+K LK G +F +E ++ H N++
Sbjct: 21 EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
RL G + +++ +M NG++ S L+ + Q+ +
Sbjct: 81 RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV 117
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 62
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 106
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 62
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ 106
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 62
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 106
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 64
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 65 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 108
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 62
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ 106
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 64
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 65 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 108
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 64
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 65 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 108
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/105 (25%), Positives = 54/105 (51%), Gaps = 3/105 (2%)
Query: 290 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE 348
++ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E
Sbjct: 5 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 62
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
++ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 63 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 107
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGE------IQFQTEVEM 349
A + + +GKGGFG V+KG L +D +VVA+K L G++ G +FQ EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL 387
+S H N+++L G M R +V ++ G + RL
Sbjct: 77 MSNLNHPNIVKLYGL-MHNPPR-MVMEFVPCGDLYHRL 112
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 62
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 106
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 67
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 111
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGE------IQFQTEVEM 349
A + + +GKGGFG V+KG L +D +VVA+K L G++ G +FQ EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL 387
+S H N+++L G M R +V ++ G + RL
Sbjct: 77 MSNLNHPNIVKLYGL-MHNPPR-MVMEFVPCGDLYHRL 112
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 67
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 111
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 26/97 (26%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 304 KNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
+ ++G G FG V +G L+ + VA+K LK G +F +E ++ H N++
Sbjct: 19 EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
RL G + +++ +M NG++ S L+ + Q+ +
Sbjct: 79 RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV 115
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 18 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 75
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 76 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 119
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGE------IQFQTEVEM 349
A + + +GKGGFG V+KG L +D +VVA+K L G++ G +FQ EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL 387
+S H N+++L G M R +V ++ G + RL
Sbjct: 77 MSNLNHPNIVKLYGL-MHNPPR-MVMEFVPCGDLYHRL 112
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E ++ H N
Sbjct: 11 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 68
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
L++L+G C ++ +M+ G++ L+ RQ
Sbjct: 69 LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ 104
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 62
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 106
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/86 (32%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG V+ GY + T VAVK LK G +Q F E ++ H L+RL
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 366 MTTTERLLVYPYMSNGSVASRLKGSK 391
++ YM+ GS+ LK +
Sbjct: 78 TREEPIYIITEYMAKGSLLDFLKSDE 103
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 269
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 313
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 308
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 352
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEM 349
+ + + ++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E +
Sbjct: 209 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAV 266
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
+ H NL++L+G C ++ +M+ G++ L+ RQ
Sbjct: 267 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 310
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDGTVV----AVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ ++G G FG VYKG ++ +G V A+K L + ++F E +++
Sbjct: 38 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 97
Query: 354 VHRNLLRLIGFCMTTTERLL 373
H +L+RL+G C++ T +L+
Sbjct: 98 DHPHLVRLLGVCLSPTIQLV 117
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
++ + K+ +G G +G VY+G + ++ VAVK LK+ E F E ++ H N
Sbjct: 11 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 68
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
L++L+G C ++ +M+ G++ L+ RQ
Sbjct: 69 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 104
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDGTVV----AVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ ++G G FG VYKG ++ +G V A+K L + ++F E +++
Sbjct: 15 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 74
Query: 354 VHRNLLRLIGFCMTTTERLL 373
H +L+RL+G C++ T +L+
Sbjct: 75 DHPHLVRLLGVCLSPTIQLV 94
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK GN F E +++ H L++L + +
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 248
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 249 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYL 278
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG V+ GY + T VAVK LK G +Q F E ++ H L+RL
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 366 MTTTERLLVYPYMSNGSVASRLKGSK 391
++ +M+ GS+ LK +
Sbjct: 77 TKEEPIYIITEFMAKGSLLDFLKSDE 102
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 22/81 (27%), Positives = 45/81 (55%), Gaps = 5/81 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 19 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 354 VHRNLLRLIGFCMTTTERLLV 374
+ ++ RL+G C+T+T +L++
Sbjct: 79 DNPHVCRLLGICLTSTVQLIM 99
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 33/117 (28%), Positives = 52/117 (44%), Gaps = 6/117 (5%)
Query: 284 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAIGG 339
G R +E+++ S + ++G G G V G L Q VA+K LK G
Sbjct: 36 GRAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ 93
Query: 340 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
F +E ++ H N++RL G ++V YM NGS+ + L+ Q+ I
Sbjct: 94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 3/96 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
++ + K+ +G G +G VY G + ++ VAVK LK+ E F E ++ H N
Sbjct: 32 TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 89
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
L++L+G C +V YM G++ L+ R+
Sbjct: 90 LVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE 125
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 22/81 (27%), Positives = 45/81 (55%), Gaps = 5/81 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 16 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 354 VHRNLLRLIGFCMTTTERLLV 374
+ ++ RL+G C+T+T +L++
Sbjct: 76 DNPHVCRLLGICLTSTVQLIM 96
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 22/81 (27%), Positives = 45/81 (55%), Gaps = 5/81 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 354 VHRNLLRLIGFCMTTTERLLV 374
+ ++ RL+G C+T+T +L++
Sbjct: 75 DNPHVCRLLGICLTSTVQLIM 95
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 22/81 (27%), Positives = 45/81 (55%), Gaps = 5/81 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 19 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 354 VHRNLLRLIGFCMTTTERLLV 374
+ ++ RL+G C+T+T +L++
Sbjct: 79 DNPHVCRLLGICLTSTVQLIM 99
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 22/81 (27%), Positives = 45/81 (55%), Gaps = 5/81 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 354 VHRNLLRLIGFCMTTTERLLV 374
+ ++ RL+G C+T+T +L++
Sbjct: 77 DNPHVCRLLGICLTSTVQLIM 97
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G G V+ GY T VAVK LK G+ F E ++ H+ L+RL + +
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
T E + ++ YM NGS+ LK
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLK 99
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V G + VA+K +K+G+ E +F E +++ H L++L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 367 TTTERLLVYPYMSNGSVASRLKGSKRQY 394
++ YM+NG + + L+ + ++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRHRF 117
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 33/117 (28%), Positives = 52/117 (44%), Gaps = 6/117 (5%)
Query: 284 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAIGG 339
G R +E+++ S + ++G G G V G L Q VA+K LK G
Sbjct: 36 GRAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ 93
Query: 340 EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
F +E ++ H N++RL G ++V YM NGS+ + L+ Q+ I
Sbjct: 94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 22/81 (27%), Positives = 45/81 (55%), Gaps = 5/81 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 16 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 354 VHRNLLRLIGFCMTTTERLLV 374
+ ++ RL+G C+T+T +L++
Sbjct: 76 DNPHVCRLLGICLTSTVQLIM 96
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 22/81 (27%), Positives = 45/81 (55%), Gaps = 5/81 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 354 VHRNLLRLIGFCMTTTERLLV 374
+ ++ RL+G C+T+T +L++
Sbjct: 77 DNPHVCRLLGICLTSTVQLIM 97
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V G + VA+K +K+G+ E +F E +++ H L++L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 367 TTTERLLVYPYMSNGSVASRLKGSKRQY 394
++ YM+NG + + L+ + ++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRHRF 117
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 22/81 (27%), Positives = 45/81 (55%), Gaps = 5/81 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDGTVV----AVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G V A+K L++ + + E +++
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 354 VHRNLLRLIGFCMTTTERLLV 374
+ ++ RL+G C+T+T +L++
Sbjct: 77 DNPHVCRLLGICLTSTVQLIM 97
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 22/81 (27%), Positives = 45/81 (55%), Gaps = 5/81 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 354 VHRNLLRLIGFCMTTTERLLV 374
+ ++ RL+G C+T+T +L++
Sbjct: 78 DNPHVCRLLGICLTSTVQLIM 98
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 38/118 (32%), Positives = 55/118 (46%), Gaps = 21/118 (17%)
Query: 291 FKELQSATSNFSSKNLV-----GKGGFGNVYK----------GYLQDGTVVAVKRLKDGN 335
FK L+ F KNLV G+G FG V K GY T VAVK LK+ N
Sbjct: 10 FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGY----TTVAVKMLKE-N 64
Query: 336 AIGGEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR 392
A E++ +E ++ H ++++L G C LL+ Y GS+ L+ S++
Sbjct: 65 ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 38/118 (32%), Positives = 55/118 (46%), Gaps = 21/118 (17%)
Query: 291 FKELQSATSNFSSKNLV-----GKGGFGNVYK----------GYLQDGTVVAVKRLKDGN 335
FK L+ F KNLV G+G FG V K GY T VAVK LK+ N
Sbjct: 10 FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGY----TTVAVKMLKE-N 64
Query: 336 AIGGEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR 392
A E++ +E ++ H ++++L G C LL+ Y GS+ L+ S++
Sbjct: 65 ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 41.6 bits (96), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 38/118 (32%), Positives = 55/118 (46%), Gaps = 21/118 (17%)
Query: 291 FKELQSATSNFSSKNLV-----GKGGFGNVYK----------GYLQDGTVVAVKRLKDGN 335
FK L+ F KNLV G+G FG V K GY T VAVK LK+ N
Sbjct: 10 FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGY----TTVAVKMLKE-N 64
Query: 336 AIGGEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR 392
A E++ +E ++ H ++++L G C LL+ Y GS+ L+ S++
Sbjct: 65 ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 41.6 bits (96), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 77 DNPHVCRLLGICLTSTVQLI 96
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 41.6 bits (96), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDGTVV----AVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G V A+K L++ + + E +++
Sbjct: 21 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 81 DNPHVCRLLGICLTSTVQLI 100
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 41.6 bits (96), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 75 DNPHVCRLLGICLTSTVQLI 94
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V G + VA+K +K+G+ E +F E +++ H L++L G C
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 367 TTTERLLVYPYMSNGSVASRLKGSKRQY 394
++ YM+NG + + L+ + ++
Sbjct: 74 KQRPIFIITEYMANGCLLNYLREMRHRF 101
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDGTVV----AVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G V A+K L++ + + E +++
Sbjct: 25 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 85 DNPHVCRLLGICLTSTVQLI 104
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 78 DNPHVCRLLGICLTSTVQLI 97
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V G + VA+K +K+G+ E +F E +++ H L++L G C
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 367 TTTERLLVYPYMSNGSVASRLKGSKRQY 394
++ YM+NG + + L+ + ++
Sbjct: 75 KQRPIFIITEYMANGCLLNYLREMRHRF 102
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V G + VA+K +K+G+ E +F E +++ H L++L G C
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 367 TTTERLLVYPYMSNGSVASRLKGSKRQY 394
++ YM+NG + + L+ + ++
Sbjct: 75 KQRPIFIITEYMANGCLLNYLREMRHRF 102
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 78 DNPHVCRLLGICLTSTVQLI 97
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDGTVV----AVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G V A+K L++ + + E +++
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 77 DNPHVCRLLGICLTSTVQLI 96
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 78 DNPHVCRLLGICLTSTVQLI 97
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 75 DNPHVCRLLGICLTSTVQLI 94
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 75 DNPHVCRLLGICLTSTVQLI 94
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V G + VA+K +K+G+ E +F E +++ H L++L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 367 TTTERLLVYPYMSNGSVASRLKGSKRQY 394
++ YM+NG + + L+ + ++
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRHRF 97
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 40 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 100 DNPHVCRLLGICLTSTVQLI 119
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 22 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 82 DNPHVCRLLGICLTSTVQLI 101
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V G + VA+K +K+G+ E +F E +++ H L++L G C
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 367 TTTERLLVYPYMSNGSVASRLKGSKRQY 394
++ YM+NG + + L+ + ++
Sbjct: 81 KQRPIFIITEYMANGCLLNYLREMRHRF 108
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 69 DNPHVCRLLGICLTSTVQLI 88
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 12 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 72 DNPHVCRLLGICLTSTVQLI 91
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 22 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 82 DNPHVCRLLGICLTSTVQLI 101
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 24/100 (24%), Positives = 45/100 (45%), Gaps = 2/100 (2%)
Query: 294 LQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 351
L+ + + + ++G GGFG VY+ + + D V R I I+ + E ++ +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
+ H N++ L G C+ LV + G + L G +
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR 101
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDGTVV----AVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G V A+K L++ + + E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 75 DNPHVCRLLGICLTSTVQLI 94
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/109 (28%), Positives = 52/109 (47%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KE+++ S + + ++G G FG V G L+ VA+K LK G F E
Sbjct: 17 KEIEA--SCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEA 74
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++ L G + ++V YM NGS+ + LK + Q+ +
Sbjct: 75 SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 1/86 (1%)
Query: 296 SATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
S++S F +G G + VYKG + G VA+K +K + G E+ ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSN 380
H N++RL T + LV+ +M N
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDN 87
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 71
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 72 VSEEPIXIVTEYMSKGSLLDFLKGETGKYL 101
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 13/110 (11%)
Query: 296 SATSNFSSKNL-----VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQT 345
S + F ++L +GKG FG+V LQD G VVAVK+L+ F+
Sbjct: 2 SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFER 60
Query: 346 EVEMISLAVHRNLLRLIGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
E+E++ H N+++ G C + R L+ Y+ GS+ L+ K +
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 110
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 82 VSEEPIYIVIEYMSKGSLLDFLKGEMGKYL 111
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 330
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGKYL 360
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 13/110 (11%)
Query: 296 SATSNFSSKNL-----VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQT 345
S + F ++L +GKG FG+V LQD G VVAVK+L+ F+
Sbjct: 2 SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFER 60
Query: 346 EVEMISLAVHRNLLRLIGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
E+E++ H N+++ G C + R L+ Y+ GS+ L+ K +
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 110
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 82 VSEEPIYIVIEYMSKGSLLDFLKGEMGKYL 111
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 74
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 75 VSEEPIYIVTEYMSKGSLLDFLKGETGKYL 104
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYL 277
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKIRHEKLVQL--YAV 81
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 82 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYL 111
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYL 277
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 72
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 73 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYL 102
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 70
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 71 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYL 100
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 82 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYL 111
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 82 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYL 111
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 307 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG VY+G +D T VAVK + + ++ I+F E ++ +++R
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLK 388
L+G L+V M++G + S L+
Sbjct: 82 LLGVVSKGQPTLVVMELMAHGDLKSYLR 109
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 307 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG VY+G +D T VAVK + + ++ I+F E ++ +++R
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLK 388
L+G L+V M++G + S L+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLR 112
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 307 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG VY+G +D T VAVK + + ++ I+F E ++ +++R
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLK 388
L+G L+V M++G + S L+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLR 112
>pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into
An Electron Microscopy Single Particle Reconstruction
pdb|3J0A|B Chain B, Homology Model Of Human Toll-Like Receptor 5 Fitted Into
An Electron Microscopy Single Particle Reconstruction
Length = 844
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 31/85 (36%), Positives = 39/85 (45%), Gaps = 4/85 (4%)
Query: 118 LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177
LS L L L++N+ P SHL L+ L LN+N LT L + L LD+S N
Sbjct: 479 LSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRN 536
Query: 178 NLSGPVPSFHA--KTFNITGNSLIC 200
L P P +IT N IC
Sbjct: 537 QLLAPNPDVFVSLSVLDITHNKFIC 561
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 22 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 80
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
G C + R L+ Y+ GS+ L+ K +
Sbjct: 81 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 114
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 17 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 75
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
G C + R L+ Y+ GS+ L+ K +
Sbjct: 76 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 109
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARR 136
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 307 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG VY+G +D T VAVK + + ++ I+F E ++ +++R
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLK 388
L+G L+V M++G + S L+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLR 112
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 23 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 81
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
G C + R L+ Y+ GS+ L+ K +
Sbjct: 82 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 115
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 107
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
G C + R L+ Y+ GS+ L+ K +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 141
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 16 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 74
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
G C + R L+ Y+ GS+ L+ K +
Sbjct: 75 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 108
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 307 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG VY+G +D T VAVK + + ++ I+F E ++ +++R
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLK 388
L+G L+V M++G + S L+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLR 112
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 79
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
G C + R L+ Y+ GS+ L+ K +
Sbjct: 80 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 113
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 82 VSEEPIYIVCEYMSKGSLLDFLKGEMGKYL 111
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 304 KNLVGKGGFGNVYKGYLQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLL 359
++++G+G FG V K ++ DG + A+KR+K+ + F E+E++ L H N++
Sbjct: 20 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
L+G C L Y +G++ L+ S+
Sbjct: 80 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 111
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 307 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG VY+G +D T VAVK + + ++ I+F E ++ +++R
Sbjct: 26 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLK 388
L+G L+V M++G + S L+
Sbjct: 86 LLGVVSKGQPTLVVMELMAHGDLKSYLR 113
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 307 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG VY+G +D T VAVK + + ++ I+F E ++ +++R
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLK 388
L+G L+V M++G + S L+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLR 112
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 25 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 83
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
G C + R L+ Y+ GS+ L+ K +
Sbjct: 84 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 117
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 76
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
G C + R L+ Y+ GS+ L+ K +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 110
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 24 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 82
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
G C + R L+ Y+ GS+ L+ K +
Sbjct: 83 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 116
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 19 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 77
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
G C + R L+ Y+ GS+ L+ K +
Sbjct: 78 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 111
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 304 KNLVGKGGFGNVYKGYLQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLL 359
++++G+G FG V K ++ DG + A+KR+K+ + F E+E++ L H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
L+G C L Y +G++ L+ S+
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 121
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 304 KNLVGKGGFGNVYKGYLQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLL 359
++++G+G FG V K ++ DG + A+KR+K+ + F E+E++ L H N++
Sbjct: 27 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
L+G C L Y +G++ L+ S+
Sbjct: 87 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 118
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/121 (23%), Positives = 52/121 (42%), Gaps = 13/121 (10%)
Query: 289 FHFKELQSATSNFSSK---------NLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGN 335
F F++ A F+ + ++G G FG V G L+ VA+K LK G
Sbjct: 10 FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 336 AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYF 395
F +E ++ H N++ L G +++ YM NGS+ + L+ + ++
Sbjct: 70 TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 396 I 396
+
Sbjct: 130 V 130
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 94
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
G C + R L+ Y+ GS+ L+ K +
Sbjct: 95 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 128
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS GS+ LKG +Y
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFLKGETGKYL 277
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 94
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
G C + R L+ Y+ GS+ L+ K +
Sbjct: 95 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 128
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 307 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG VY+G +D T VAVK + + ++ I+F E ++ +++R
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLK 388
L+G L+V M++G + S L+
Sbjct: 84 LLGVVSKGQPTLVVMELMAHGDLKSYLR 111
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 21/81 (25%), Positives = 44/81 (54%), Gaps = 5/81 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++ G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 22 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 354 VHRNLLRLIGFCMTTTERLLV 374
+ ++ RL+G C+T+T +L++
Sbjct: 82 DNPHVCRLLGICLTSTVQLIM 102
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 21/80 (26%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++ G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 15 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 75 DNPHVCRLLGICLTSTVQLI 94
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 21/80 (26%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++ G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 22 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 82 DNPHVCRLLGICLTSTVQLI 101
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 42/95 (44%), Gaps = 3/95 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGT-VVAVKRLKDGN--AIGGEIQFQTEVEMISLAVH 355
+F +GKG FGNVY + +VA+K L G E Q + E+E+ + H
Sbjct: 23 DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGS 390
N+LRL + L+ Y G + L+ S
Sbjct: 83 PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS 117
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 21/80 (26%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+ L++ + + E +++
Sbjct: 49 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 354 VHRNLLRLIGFCMTTTERLL 373
+ ++ RL+G C+T+T +L+
Sbjct: 109 DNPHVCRLLGICLTSTVQLI 128
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YM+ GS+ LKG +Y
Sbjct: 79 VSEEPIYIVTEYMNKGSLLDFLKGETGKYL 108
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARR 136
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YM+ GS+ LKG +Y
Sbjct: 79 VSEEPIYIVTEYMNKGSLLDFLKGETGKYL 108
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 287 KRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGE 340
K+ KE+ + F + +G+ FG VYKG+L + VA+K LKD
Sbjct: 16 KQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR 73
Query: 341 IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 383
+F+ E + + H N++ L+G +++ Y S+G +
Sbjct: 74 EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 116
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 30 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 90 IINLLGACTQDGPLYVIVEYASKGNLREYLRARR 123
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARR 182
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V G + VAVK +K+G+ E FQ M+ L+ H L++ G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEF-FQEAQTMMKLS-HPKLVKFYGVCS 73
Query: 367 TTTERLLVYPYMSNGSVASRLK 388
+V Y+SNG + + L+
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLR 95
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 35 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 95 IINLLGACTQDGPLYVIVEYASKGNLREYLRARR 128
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 79
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKG 389
G C + R L+ Y+ GS+ L+
Sbjct: 80 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQA 109
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 29/108 (26%), Positives = 52/108 (48%), Gaps = 13/108 (12%)
Query: 284 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF 343
G+L +KE++ + +VG+G FG V K + VA+K+++ + F
Sbjct: 1 GSLHMIDYKEIEV-------EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---F 49
Query: 344 QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
E+ +S H N+++L G C+ LV Y GS+ + L G++
Sbjct: 50 IVELRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAE 95
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS G + LKG +Y
Sbjct: 82 VSEEPIYIVMEYMSKGCLLDFLKGEMGKYL 111
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 32 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 92 IINLLGACTQDGPLYVIVEYASKGNLREYLRARR 125
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 346
E + A + +G+G FG VY KG ++D T VA+K + + ++ I+F E
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
++ +++RL+G L++ M+ G + S L+
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 307 VGKGGFG--NVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
+G+GGF ++ +G L DG A+KR+ E + Q E +M L H N+LRL+ +
Sbjct: 37 LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDRE-EAQREADMHRLFNHPNILRLVAY 94
Query: 365 CM----TTTERLLVYPYMSNGSVASRLKGSK 391
C+ E L+ P+ G++ + ++ K
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLK 125
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 346
E + A + +G+G FG VY KG ++D T VA+K + + ++ I+F E
Sbjct: 4 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
++ +++RL+G L++ M+ G + S L+
Sbjct: 64 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 105
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 346
E + A + +G+G FG VY KG ++D T VA+K + + ++ I+F E
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
++ +++RL+G L++ M+ G + S L+
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 367 TTTERL-LVYPYMSNGSVASRLKGSKRQYF 395
+ E + +V YMS G + LKG +Y
Sbjct: 82 VSEEPIYIVTEYMSKGCLLDFLKGEMGKYL 111
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 307 VGKGGFGNV---YKGYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+GKG FG+V LQD G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 79
Query: 362 IGFCMTTTER--LLVYPYMSNGSVASRLKGSKRQ 393
G C + R L+ ++ GS+ L+ K +
Sbjct: 80 KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER 113
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 346
E + A + +G+G FG VY KG ++D T VA+K + + ++ I+F E
Sbjct: 13 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
++ +++RL+G L++ M+ G + S L+
Sbjct: 73 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 114
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 346
E + A + +G+G FG VY KG ++D T VA+K + + ++ I+F E
Sbjct: 10 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
++ +++RL+G L++ M+ G + S L+
Sbjct: 70 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 111
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 346
E + A + +G+G FG VY KG ++D T VA+K + + ++ I+F E
Sbjct: 6 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
++ +++RL+G L++ M+ G + S L+
Sbjct: 66 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 107
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 25/97 (25%), Positives = 45/97 (46%), Gaps = 4/97 (4%)
Query: 304 KNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
+ ++G G FG V G L+ VA+K LK G F +E ++ H N++
Sbjct: 13 EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
L G +++ YM NGS+ + L+ + ++ +
Sbjct: 73 HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV 109
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 25/97 (25%), Positives = 45/97 (46%), Gaps = 4/97 (4%)
Query: 304 KNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
+ ++G G FG V G L+ VA+K LK G F +E ++ H N++
Sbjct: 19 EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
L G +++ YM NGS+ + L+ + ++ +
Sbjct: 79 HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV 115
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 346
E + A + +G+G FG VY KG ++D T VA+K + + ++ I+F E
Sbjct: 12 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
++ +++RL+G L++ M+ G + S L+
Sbjct: 72 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 113
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 346
E + A + +G+G FG VY KG ++D T VA+K + + ++ I+F E
Sbjct: 6 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
++ +++RL+G L++ M+ G + S L+
Sbjct: 66 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 107
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 346
E + A + +G+G FG VY KG ++D T VA+K + + ++ I+F E
Sbjct: 9 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
++ +++RL+G L++ M+ G + S L+
Sbjct: 69 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 110
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 346
E + A + +G+G FG VY KG ++D T VA+K + + ++ I+F E
Sbjct: 12 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
++ +++RL+G L++ M+ G + S L+
Sbjct: 72 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 113
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 346
E + A + +G+G FG VY KG ++D T VA+K + + ++ I+F E
Sbjct: 13 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
++ +++RL+G L++ M+ G + S L+
Sbjct: 73 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 114
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTE 346
E + A + +G+G FG VY KG ++D T VA+K + + ++ I+F E
Sbjct: 41 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 100
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
++ +++RL+G L++ M+ G + S L+
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 142
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 37.4 bits (85), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 8/99 (8%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQ 344
KE+ + F + +G+ FG VYKG+L + VA+K LKD +F+
Sbjct: 3 LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 345 TEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 383
E + + H N++ L+G +++ Y S+G +
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 99
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 37.4 bits (85), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 1/89 (1%)
Query: 301 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
F+ + +GKG FG VYKG VVA+K + A Q E+ ++S +
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLK 388
R G + +T+ ++ Y+ GS LK
Sbjct: 81 RYFGSYLKSTKLWIIMEYLGGGSALDLLK 109
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 37.4 bits (85), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 37/72 (51%), Gaps = 2/72 (2%)
Query: 298 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVH 355
S + +G+G FG V+K + + G VA+K+ L + G I E++++ L H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 356 RNLLRLIGFCMT 367
N++ LI C T
Sbjct: 77 ENVVNLIEICRT 88
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 37.0 bits (84), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 21/73 (28%), Positives = 40/73 (54%), Gaps = 6/73 (8%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+++ ++G G FG VY+ L D G +VA+K++ G A E++++ H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-----ELQIMRKLDHCNI 75
Query: 359 LRLIGFCMTTTER 371
+RL F ++ E+
Sbjct: 76 VRLRYFFYSSGEK 88
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 21/73 (28%), Positives = 40/73 (54%), Gaps = 6/73 (8%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+++ ++G G FG VY+ L D G +VA+K++ G A E++++ H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-----ELQIMRKLDHCNI 75
Query: 359 LRLIGFCMTTTER 371
+RL F ++ E+
Sbjct: 76 VRLRYFFYSSGEK 88
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 21/73 (28%), Positives = 40/73 (54%), Gaps = 6/73 (8%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+++ ++G G FG VY+ L D G +VA+K++ G A E++++ H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-----ELQIMRKLDHCNI 75
Query: 359 LRLIGFCMTTTER 371
+RL F ++ E+
Sbjct: 76 VRLRYFFYSSGEK 88
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 37/72 (51%), Gaps = 2/72 (2%)
Query: 298 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVH 355
S + +G+G FG V+K + + G VA+K+ L + G I E++++ L H
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 356 RNLLRLIGFCMT 367
N++ LI C T
Sbjct: 76 ENVVNLIEICRT 87
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 3/97 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVH 355
+F +GKG FGNVY Q+ ++A+K L G E Q + E+E+ S H
Sbjct: 14 DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR 392
N+LR+ + L+ + G + L+ R
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR 110
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 3/97 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVH 355
+F +GKG FGNVY Q+ ++A+K L G E Q + E+E+ S H
Sbjct: 15 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR 392
N+LR+ + L+ + G + L+ R
Sbjct: 75 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR 111
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 3/97 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVH 355
+F +GKG FGNVY Q+ ++A+K L G E Q + E+E+ S H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR 392
N+LR+ + L+ + G + L+ R
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR 110
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 37.0 bits (84), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 24/62 (38%), Positives = 33/62 (53%), Gaps = 2/62 (3%)
Query: 290 HFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEV 347
H KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V
Sbjct: 22 HMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 81
Query: 348 EM 349
M
Sbjct: 82 PM 83
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 37.0 bits (84), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 37/74 (50%), Gaps = 2/74 (2%)
Query: 298 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVH 355
S + +G+G FG V+K + + G VA+K+ L + G I E++++ L H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 356 RNLLRLIGFCMTTT 369
N++ LI C T
Sbjct: 77 ENVVNLIEICRTKA 90
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 37.0 bits (84), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 29/109 (26%), Positives = 48/109 (44%), Gaps = 6/109 (5%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEV 347
KEL + S + ++G G FG V G L+ VA+K LK G F E
Sbjct: 38 KELDA--SCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEA 95
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
++ H N++ L G ++V +M NG++ + L+ Q+ +
Sbjct: 96 SIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 36.6 bits (83), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 37/74 (50%), Gaps = 2/74 (2%)
Query: 298 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVH 355
S + +G+G FG V+K + + G VA+K+ L + G I E++++ L H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 356 RNLLRLIGFCMTTT 369
N++ LI C T
Sbjct: 77 ENVVNLIEICRTKA 90
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 36.6 bits (83), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 24/86 (27%), Positives = 44/86 (51%), Gaps = 7/86 (8%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ ++G G FG VYKG ++ DG VA+K L++ + + E +++
Sbjct: 17 TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 76
Query: 354 VHRNLLRLIGFCMTTTERLL--VYPY 377
+ RL+G C+T+T +L+ + PY
Sbjct: 77 GSPYVSRLLGICLTSTVQLVTQLMPY 102
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 36.6 bits (83), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 1/88 (1%)
Query: 294 LQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISL 352
Q + VG+G +G VYK G +VA+KR++ D G E+ ++
Sbjct: 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 353 AVHRNLLRLIGFCMTTTERLLVYPYMSN 380
H N++ LI + LV+ +M
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK 103
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 36.6 bits (83), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 48/98 (48%), Gaps = 4/98 (4%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVH 355
NF ++GKG FG V +++ G + AVK LK + + TE ++SLA +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 356 RNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKGSKR 392
L + C T +RL V +++ G + ++ S+R
Sbjct: 83 HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR 120
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 36.6 bits (83), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 1/88 (1%)
Query: 294 LQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISL 352
Q + VG+G +G VYK G +VA+KR++ D G E+ ++
Sbjct: 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 353 AVHRNLLRLIGFCMTTTERLLVYPYMSN 380
H N++ LI + LV+ +M
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK 103
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 43/85 (50%), Gaps = 2/85 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMS 379
H N+++L+ T + LV+ ++S
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLS 88
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 43/85 (50%), Gaps = 2/85 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMS 379
H N+++L+ T + LV+ ++S
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFLS 87
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 43/85 (50%), Gaps = 2/85 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMS 379
H N+++L+ T + LV+ ++S
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFLS 88
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 36.2 bits (82), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 43/85 (50%), Gaps = 2/85 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMS 379
H N+++L+ T + LV+ ++S
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFLS 86
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 36.2 bits (82), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 28/107 (26%), Positives = 51/107 (47%), Gaps = 13/107 (12%)
Query: 285 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQ 344
+L +KE++ + +VG+G FG V K + VA+K+++ + F
Sbjct: 1 SLHMIDYKEIEV-------EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---FI 49
Query: 345 TEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
E+ +S H N+++L G C+ LV Y GS+ + L G++
Sbjct: 50 VELRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAE 94
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 35.8 bits (81), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 45/88 (51%), Gaps = 4/88 (4%)
Query: 296 SATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISL 352
+ + + LVG+G +G V K +D G +VA+K+ D + + +I + E++++
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQ 80
Query: 353 AVHRNLLRLIGFCMTTTERLLVYPYMSN 380
H NL+ L+ C LV+ ++ +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH 108
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 35.8 bits (81), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 8/104 (7%)
Query: 299 SNFSSKNLVGKGGFGNVYK----GYLQDGTV--VAVKRLKDGNAIGGEIQFQTEVEMIS- 351
N ++G G FG V G + G VAVK LK+ +E++M++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYF 395
L H N++ L+G C + L++ Y G + + L+ SKR+ F
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR-SKREKF 147
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 35.8 bits (81), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 290 HFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVE 348
++ E++++ S++ +G G FG VYKG VAVK LK + + Q F+ EV
Sbjct: 29 YYWEIEASEVMLSTR--IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVA 84
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL 387
++ H N+L +G+ MT +V + S+ L
Sbjct: 85 VLRKTRHVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHL 122
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 35.8 bits (81), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 9/89 (10%)
Query: 307 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG V Y D G +VAVK LK+G +Q E+E++ H ++++
Sbjct: 17 LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 361 LIGFCMTTTER--LLVYPYMSNGSVASRL 387
G C E+ LV Y+ GS+ L
Sbjct: 76 YKGCCEDQGEKSVQLVMEYVPLGSLRDYL 104
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 35.8 bits (81), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 9/89 (10%)
Query: 307 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG V Y D G +VAVK LK+G +Q E+E++ H ++++
Sbjct: 16 LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 361 LIGFCMTTTER--LLVYPYMSNGSVASRL 387
G C E+ LV Y+ GS+ L
Sbjct: 75 YKGCCEDQGEKSVQLVMEYVPLGSLRDYL 103
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 35.4 bits (80), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 52/103 (50%), Gaps = 11/103 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYL--QDGTV--VAVKRLKDGNAIGGEI-QFQTEVEMISLAV 354
F+ ++GKG FG+V + L +DG+ VAVK LK +I +F E +
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 355 HRNLLRLIGFCMTTTER------LLVYPYMSNGSVASRLKGSK 391
H ++ +L+G + + + +++ P+M +G + + L S+
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 35.4 bits (80), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 26/101 (25%), Positives = 47/101 (46%), Gaps = 9/101 (8%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKR-----LKDGNAIGGEIQFQTEVEMISL 352
+NF + +G+G F VY+ L DG VA+K+ L D A I+ E++++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQ 88
Query: 353 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
H N+++ + E +V G ++ +K K+Q
Sbjct: 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ 129
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 35.4 bits (80), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 10/110 (9%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQ-FQTEVEMISLAVH 355
+F NL+GKG F VY+ + G VA+K + K G +Q Q EV++ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKG-------SKRQYFIHK 398
++L L + + LV NG + LK ++ ++F+H+
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 35.4 bits (80), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 34 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 87
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 88 IVRLRYFFYSSGEK 101
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 35.4 bits (80), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 22 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 75
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 76 IVRLRYFFYSSGEK 89
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 35.4 bits (80), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 75 IVRLRYFFYSSGEK 88
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 35.4 bits (80), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 75 IVRLRYFFYSSGEK 88
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 35.4 bits (80), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 75 IVRLRYFFYSSGEK 88
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 35.4 bits (80), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 75 IVRLRYFFYSSGEK 88
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 35.0 bits (79), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 40 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 93
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 94 IVRLRYFFYSSGEK 107
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 35.0 bits (79), Expect = 0.066, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 29 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 82
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 83 IVRLRYFFYSSGEK 96
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 35.0 bits (79), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 86
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 87 IVRLRYFFYSSGEK 100
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 35.0 bits (79), Expect = 0.068, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 49 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 102
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 103 IVRLRYFFYSSGEK 116
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 35.0 bits (79), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 26 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 79
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 80 IVRLRYFFYSSGEK 93
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 35.0 bits (79), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 108
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 109 IVRLRYFFYSSGEK 122
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 35.0 bits (79), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 43/92 (46%), Gaps = 2/92 (2%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNL 358
+ + K +G G FG V++ G+ VAVK L + + + +F EV ++ H N+
Sbjct: 38 DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKGS 390
+ +G +V Y+S GS+ L S
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS 128
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 35.0 bits (79), Expect = 0.070, Method: Compositional matrix adjust.
Identities = 26/100 (26%), Positives = 45/100 (45%), Gaps = 6/100 (6%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 352
A + ++G+G FG VY+G + VAVK K + + +F +E ++
Sbjct: 6 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 353 AVHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKGS 390
H ++++LIG ++ +YPY G R K S
Sbjct: 66 LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNS 105
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 35.0 bits (79), Expect = 0.071, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 86
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 87 IVRLRYFFYSSGEK 100
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 35.0 bits (79), Expect = 0.071, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 108
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 109 IVRLRYFFYSSGEK 122
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 35.0 bits (79), Expect = 0.071, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 25 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 78
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 79 IVRLRYFFYSSGEK 92
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 35.0 bits (79), Expect = 0.072, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 43/92 (46%), Gaps = 2/92 (2%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNL 358
+ + K +G G FG V++ G+ VAVK L + + + +F EV ++ H N+
Sbjct: 38 DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKGS 390
+ +G +V Y+S GS+ L S
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS 128
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 35.0 bits (79), Expect = 0.075, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 57 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 110
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 111 IVRLRYFFYSSGEK 124
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 35.0 bits (79), Expect = 0.075, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 153
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 154 IVRLRYFFYSSGEK 167
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 35.0 bits (79), Expect = 0.078, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H N
Sbjct: 59 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 112
Query: 358 LLRLIGFCMTTTER 371
++RL F ++ E+
Sbjct: 113 IVRLRYFFYSSGEK 126
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 35.0 bits (79), Expect = 0.079, Method: Compositional matrix adjust.
Identities = 26/100 (26%), Positives = 45/100 (45%), Gaps = 6/100 (6%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 352
A + ++G+G FG VY+G + VAVK K + + +F +E ++
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 353 AVHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKGS 390
H ++++LIG ++ +YPY G R K S
Sbjct: 70 LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNS 109
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 35.0 bits (79), Expect = 0.080, Method: Compositional matrix adjust.
Identities = 26/100 (26%), Positives = 45/100 (45%), Gaps = 6/100 (6%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 352
A + ++G+G FG VY+G + VAVK K + + +F +E ++
Sbjct: 22 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 353 AVHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKGS 390
H ++++LIG ++ +YPY G R K S
Sbjct: 82 LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNS 121
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 35.0 bits (79), Expect = 0.084, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 34.7 bits (78), Expect = 0.085, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+K+++ D G E+ ++ H
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 67 NIVKLLDVIHTENKLYLVFEFL 88
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 34.7 bits (78), Expect = 0.087, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 34.7 bits (78), Expect = 0.087, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 34.7 bits (78), Expect = 0.088, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 34.7 bits (78), Expect = 0.088, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 34.7 bits (78), Expect = 0.089, Method: Compositional matrix adjust.
Identities = 23/103 (22%), Positives = 46/103 (44%), Gaps = 3/103 (2%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEI-QFQTEVEM 349
K+ + +G GGF V ++ G +VA+K + D N +G ++ + +TE+E
Sbjct: 3 KDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIK-IMDKNTLGSDLPRIKTEIEA 61
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR 392
+ H+++ +L T + +V Y G + + R
Sbjct: 62 LKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDR 104
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 34.7 bits (78), Expect = 0.090, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 34.7 bits (78), Expect = 0.090, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 34.7 bits (78), Expect = 0.090, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 5 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 65 HPNIVKLLDVIHTENKLYLVFEFL 88
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 34.7 bits (78), Expect = 0.090, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 34.7 bits (78), Expect = 0.090, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 34.7 bits (78), Expect = 0.090, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 34.7 bits (78), Expect = 0.091, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|2R9U|A Chain A, Crystal Structure Of Lamprey Variable Lymphocyte Receptor
2913 Ectodomain
pdb|2R9U|B Chain B, Crystal Structure Of Lamprey Variable Lymphocyte Receptor
2913 Ectodomain
pdb|2R9U|C Chain C, Crystal Structure Of Lamprey Variable Lymphocyte Receptor
2913 Ectodomain
pdb|2R9U|D Chain D, Crystal Structure Of Lamprey Variable Lymphocyte Receptor
2913 Ectodomain
Length = 174
Score = 34.7 bits (78), Expect = 0.092, Method: Compositional matrix adjust.
Identities = 25/73 (34%), Positives = 34/73 (46%), Gaps = 6/73 (8%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 166
+ IPT+ +L L+NN T P HL LQ L N+N LT +
Sbjct: 27 VPAGIPTDKQRLW------LNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKL 80
Query: 167 SQLAFLDLSYNNL 179
+QL LDL+ N+L
Sbjct: 81 TQLTQLDLNDNHL 93
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 34.7 bits (78), Expect = 0.092, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 34.7 bits (78), Expect = 0.093, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+K+++ D G E+ ++ H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFL 85
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 34.7 bits (78), Expect = 0.093, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 34.7 bits (78), Expect = 0.095, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM 378
H N+++L+ T + LV+ ++
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 34.7 bits (78), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+K+++ D G E+ ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 34.7 bits (78), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+K+++ D G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 34.7 bits (78), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+K+++ D G E+ ++ H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFL 91
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 34.7 bits (78), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+K+++ D G E+ ++ H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFL 91
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 34.7 bits (78), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+K+++ D G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 34.7 bits (78), Expect = 0.098, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+K+++ D G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 34.7 bits (78), Expect = 0.099, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+K+++ D G E+ ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 34.7 bits (78), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+K+++ D G E+ ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 34.7 bits (78), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+K+++ D G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 34.7 bits (78), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+K+++ D G E+ ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|2Z80|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
pdb|2Z80|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
Length = 353
Score = 34.7 bits (78), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 27/70 (38%), Positives = 36/70 (51%), Gaps = 2/70 (2%)
Query: 111 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA 170
IP+ + + K +LDLSNN T S + LQ L L +N + S S++ L
Sbjct: 46 IPSGLTEAVK--SLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE 103
Query: 171 FLDLSYNNLS 180
LDLSYN LS
Sbjct: 104 HLDLSYNYLS 113
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 34.7 bits (78), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 44 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 34.7 bits (78), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 5/83 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLKPGTM--SPESFLEEAQIMKKLKHDKLVQL--YAV 72
Query: 367 TTTERL-LVYPYMSNGSVASRLK 388
+ E + +V YM+ GS+ LK
Sbjct: 73 VSEEPIYIVTEYMNKGSLLDFLK 95
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 17/86 (19%), Positives = 43/86 (50%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG VYK ++ +V+A ++ D + + E+++++ H N+++L+
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 367 TTTERLLVYPYMSNGSVASRLKGSKR 392
++ + + G+V + + +R
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER 130
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 30 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 29 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
>pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
Length = 520
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 24/67 (35%), Positives = 31/67 (46%), Gaps = 2/67 (2%)
Query: 116 GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLT--GAIPPSLSNMSQLAFLD 173
K+S L LD SNN T + HL L+ L L N L I + M L LD
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380
Query: 174 LSYNNLS 180
+S N++S
Sbjct: 381 ISQNSVS 387
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 30 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
>pdb|1IGO|A Chain A, Family 11 Xylanase
pdb|1IGO|B Chain B, Family 11 Xylanase
Length = 205
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 22/73 (30%), Positives = 33/73 (45%), Gaps = 16/73 (21%)
Query: 162 SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALN 221
S SQL + ++YN TFN GNS +C G +D P+ + ++
Sbjct: 56 STKTHSQLGNISINYN-----------ATFNPGGNSYLCVYGWTKD-----PLTEYYIVD 99
Query: 222 NSPNSKPSGMPKG 234
N +P+G PKG
Sbjct: 100 NWGTYRPTGTPKG 112
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 17/86 (19%), Positives = 43/86 (50%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG VYK ++ +V+A ++ D + + E+++++ H N+++L+
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 367 TTTERLLVYPYMSNGSVASRLKGSKR 392
++ + + G+V + + +R
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER 130
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 17/86 (19%), Positives = 43/86 (50%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG VYK ++ +V+A ++ D + + E+++++ H N+++L+
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 367 TTTERLLVYPYMSNGSVASRLKGSKR 392
++ + + G+V + + +R
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER 130
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 29 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 30 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 29 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 29 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 30 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 49 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 108
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 16 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K T VAVK LK +E+EM+ + H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARR 129
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 17 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 16 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 17 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 17 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 34.3 bits (77), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 22/86 (25%), Positives = 42/86 (48%), Gaps = 2/86 (2%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV 354
+ NF +G+G +G VYK + G VVA+K+++ D G E+ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSN 380
H N+++L+ T + LV+ ++
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEHVDQ 89
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 34.3 bits (77), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 44 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 34.3 bits (77), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K T VAVK LK +E+EM+ + H+N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARR 114
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 34.3 bits (77), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K T VAVK LK +E+EM+ + H+N
Sbjct: 25 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 85 IINLLGACTQDGPLYVIVEYASKGNLREYLQARR 118
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVE 348
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 349 M 349
M
Sbjct: 61 M 61
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVE 348
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 349 M 349
M
Sbjct: 61 M 61
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K T VAVK LK +E+EM+ + H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARR 129
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 2 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 1 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 26/101 (25%), Positives = 47/101 (46%), Gaps = 7/101 (6%)
Query: 307 VGKGGFGNVYK----GYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLL 359
+G G FG V + G ++ VAVK LK + +E++++S L H N++
Sbjct: 47 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L++ Y G + + L+ + + K+S
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 147
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 45/93 (48%), Gaps = 9/93 (9%)
Query: 307 VGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+G+G F ++KG ++ T V +K L + E F+ M+S H++L
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
+ G C+ E +LV ++ GS+ + LK +K
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK 107
>pdb|2Z7X|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
Length = 549
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 24/59 (40%), Positives = 30/59 (50%)
Query: 123 TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
+LDLSNN T S + LQ L L +N + S S++ L LDLSYN LS
Sbjct: 30 SLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN 88
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K T VAVK LK +E+EM+ + H+N
Sbjct: 28 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 88 IINLLGACTQDGPLYVIVEYASKGNLREYLQARR 121
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K T VAVK LK +E+EM+ + H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARR 129
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 31/94 (32%), Positives = 39/94 (41%), Gaps = 8/94 (8%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
N L+G+G +G VYKG L D VAVK N + + + L H N+
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNI 69
Query: 359 LRLIGFCMTTT-----ERLLVYPYMSNGSVASRL 387
R I T E LLV Y NGS+ L
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL 103
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
KE + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 1 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 35/114 (30%), Positives = 48/114 (42%), Gaps = 12/114 (10%)
Query: 294 LQSATSNFSSKNL-----VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--Q 342
LQS T K+L +G G FG V +G VAVK LK E
Sbjct: 8 LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 343 FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
F EV + HRNL+RL G +T + +V GS+ RL+ + + +
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL 120
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 26/101 (25%), Positives = 47/101 (46%), Gaps = 7/101 (6%)
Query: 307 VGKGGFGNVYK----GYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLL 359
+G G FG V + G ++ VAVK LK + +E++++S L H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L++ Y G + + L+ + + K+S
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG VAVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 20 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 366 MTTTERLLVYPYMSNGSVASRLKGSKRQYFIHK 398
T + +V + S+ L S+ ++ + K
Sbjct: 78 -TKPQLAIVTQWCEGSSLYHHLHASETKFEMKK 109
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K T VAVK LK +E+EM+ + H+N
Sbjct: 29 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 89 IINLLGACTQDGPLYVIVEYASKGNLREYLQARR 122
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 33.9 bits (76), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG VAVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 366 MTTTERLLVYPYMSNGSVASRLKGSKRQYFIHK 398
T + +V + S+ L S+ ++ + K
Sbjct: 90 -TAPQLAIVTQWCEGSSLYHHLHASETKFEMKK 121
>pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|E Chain E, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|I Chain I, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|M Chain M, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|B Chain B, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|F Chain F, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|J Chain J, Crystal Structure Of The Rp105MD-1 Complex
pdb|3RG1|N Chain N, Crystal Structure Of The Rp105MD-1 Complex
Length = 612
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 24/68 (35%), Positives = 38/68 (55%), Gaps = 1/68 (1%)
Query: 124 LDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPV 183
LDLS+N TG +SHL+ L YL + +N++ P L +SQ + ++LS+N L
Sbjct: 504 LDLSHNSLTGDSMDALSHLKGL-YLNMASNNIRIIPPHLLPALSQQSIINLSHNPLDCTC 562
Query: 184 PSFHAKTF 191
+ H T+
Sbjct: 563 SNIHFITW 570
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 303 SKNLVGKGGFGNVYKG-YL---QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
S ++GKG FG VY G Y+ Q+ A+K L + F E ++ H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 359 LRLIGFCMTTTERL--LVYPYMSNGSVASRLKGSKR 392
L LIG M E L ++ PYM +G + ++ +R
Sbjct: 85 LALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQR 119
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 35/114 (30%), Positives = 48/114 (42%), Gaps = 12/114 (10%)
Query: 294 LQSATSNFSSKNL-----VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--Q 342
LQS T K+L +G G FG V +G VAVK LK E
Sbjct: 8 LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 343 FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
F EV + HRNL+RL G +T + +V GS+ RL+ + + +
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL 120
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 9/93 (9%)
Query: 307 VGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+G+G F ++KG ++ T V +K L + E F+ M+S H++L
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
+ G C E +LV ++ GS+ + LK +K
Sbjct: 75 VLNYGVCFCGDENILVQEFVKFGSLDTYLKKNK 107
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 33.9 bits (76), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+K+++ D G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEHV 83
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 33.5 bits (75), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K T VAVK LK +E+EM+ + H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARR 170
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 33.5 bits (75), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 26/101 (25%), Positives = 47/101 (46%), Gaps = 7/101 (6%)
Query: 307 VGKGGFGNVYK----GYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLL 359
+G G FG V + G ++ VAVK LK + +E++++S L H N++
Sbjct: 49 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L++ Y G + + L+ + + K+S
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 149
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 33.5 bits (75), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 30/116 (25%), Positives = 51/116 (43%), Gaps = 12/116 (10%)
Query: 285 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGG-EIQ 342
+L L+ F LVG G +G VYKG +++ G + A+K + + G E +
Sbjct: 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEE 66
Query: 343 FQTEVEMI-SLAVHRNLLRLIGFCMTTT------ERLLVYPYMSNGSVASRLKGSK 391
+ E+ M+ + HRN+ G + + LV + GSV +K +K
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 33.5 bits (75), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG VAVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 366 MTTTERLLVYPYMSNGSVASRLKGSKRQYFIHK 398
T + +V + S+ L S+ ++ + K
Sbjct: 90 -TKPQLAIVTQWCEGSSLYHHLHASETKFEMKK 121
>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex
pdb|4B8C|J Chain J, Nuclease Module Of The Yeast Ccr4-Not Complex
pdb|4B8C|K Chain K, Nuclease Module Of The Yeast Ccr4-Not Complex
pdb|4B8C|L Chain L, Nuclease Module Of The Yeast Ccr4-Not Complex
Length = 727
Score = 33.5 bits (75), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 25/59 (42%), Positives = 33/59 (55%), Gaps = 4/59 (6%)
Query: 124 LDLSN-NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
LDLSN F I + + + L L LN NSLT +P + N+S L LDLS+N L+
Sbjct: 229 LDLSNLQIFN--ISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTS 284
Score = 33.5 bits (75), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 24/70 (34%), Positives = 35/70 (50%), Gaps = 2/70 (2%)
Query: 111 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA 170
+P EI LS L LDLS+N T +P+ + L+Y +N +T +P N+ L
Sbjct: 262 LPAEIKNLSNLRVLDLSHNRLTS-LPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQ 319
Query: 171 FLDLSYNNLS 180
FL + N L
Sbjct: 320 FLGVEGNPLE 329
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 33.5 bits (75), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 26/101 (25%), Positives = 47/101 (46%), Gaps = 7/101 (6%)
Query: 307 VGKGGFGNVYK----GYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLL 359
+G G FG V + G ++ VAVK LK + +E++++S L H N++
Sbjct: 54 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L++ Y G + + L+ + + K+S
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 33.5 bits (75), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 26/101 (25%), Positives = 47/101 (46%), Gaps = 7/101 (6%)
Query: 307 VGKGGFGNVYK----GYLQD--GTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLL 359
+G G FG V + G ++ VAVK LK + +E++++S L H N++
Sbjct: 54 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L++ Y G + + L+ + + K+S
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 33.5 bits (75), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 9/94 (9%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K T VAVK LK +E+EM+ + H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
++ L+G C ++ Y S G++ L+ +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARE 129
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 33.1 bits (74), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 26/101 (25%), Positives = 51/101 (50%), Gaps = 8/101 (7%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 36 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFIHKS 399
L+G C L+V + G++++ L+ + ++ +K+
Sbjct: 96 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 136
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 33.1 bits (74), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 20/65 (30%), Positives = 33/65 (50%), Gaps = 6/65 (9%)
Query: 300 NFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+F L+G GGFG V+K + DG +KR+K N + + EV+ ++ H N+
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----KAEREVKALAKLDHVNI 66
Query: 359 LRLIG 363
+ G
Sbjct: 67 VHYNG 71
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 33.1 bits (74), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 24/97 (24%), Positives = 43/97 (44%), Gaps = 2/97 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
S+ ++GKG FG K + + G V+ +K L + + F EV+++ H N
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-ETQRTFLKEVKVMRCLEHPN 68
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQY 394
+L+ IG + Y+ G++ +K QY
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY 105
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 33.1 bits (74), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L+V + G++++ L+ + ++ +K +
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEA 138
>pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4
pdb|2WFH|B Chain B, The Human Slit 2 Dimerization Domain D4
Length = 193
Score = 32.7 bits (73), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 25/69 (36%), Positives = 37/69 (53%), Gaps = 7/69 (10%)
Query: 111 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA 170
IP ++ +L L N FT +P +S+ + L + L+NN ++ S SNM+QL
Sbjct: 29 IPRDVTELY------LDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 171 FLDLSYNNL 179
L LSYN L
Sbjct: 82 TLILSYNRL 90
Score = 28.9 bits (63), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 20/70 (28%), Positives = 32/70 (45%)
Query: 111 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA 170
+P E+ L +DLSNN + + S++ L L L+ N L P + + L
Sbjct: 46 VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLR 105
Query: 171 FLDLSYNNLS 180
L L N++S
Sbjct: 106 LLSLHGNDIS 115
>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839
pdb|2IO6|A Chain A, Wee1 Kinase Complexed With Inhibitor Pd330961
Length = 287
Score = 32.7 bits (73), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 9/105 (8%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEV-EMISLAV- 354
T+ F +G G FG+V+K + DG + A+KR K + G + Q + E+ + AV
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 65
Query: 355 --HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR--QYF 395
H +++R L+ Y + GS+A + + R YF
Sbjct: 66 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYF 110
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 32.7 bits (73), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L+V + G++++ L+ + ++ +K +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 32.7 bits (73), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 19/65 (29%), Positives = 33/65 (50%), Gaps = 6/65 (9%)
Query: 300 NFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+F L+G GGFG V+K + DG ++R+K N + + EV+ ++ H N+
Sbjct: 13 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNE-----KAEREVKALAKLDHVNI 67
Query: 359 LRLIG 363
+ G
Sbjct: 68 VHYNG 72
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 32.7 bits (73), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGF 364
+G+G F VYKG + TV VA L+D E Q F+ E E + H N++R
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 365 CMTTTE----RLLVYPYMSNGSVASRLKGSK 391
+T + +LV ++G++ + LK K
Sbjct: 94 WESTVKGKKCIVLVTELXTSGTLKTYLKRFK 124
>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396
pdb|3BIZ|A Chain A, Wee1 Kinase Complex With Inhibitor Pd331618
pdb|3CQE|A Chain A, Wee1 Kinase Complex With Inhibitor Pd074291
pdb|3CR0|A Chain A, Wee1 Kinase Complex With Inhibitor Pd259_809
Length = 287
Score = 32.7 bits (73), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 9/105 (8%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEV-EMISLAV- 354
T+ F +G G FG+V+K + DG + A+KR K + G + Q + E+ + AV
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 65
Query: 355 --HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR--QYF 395
H +++R L+ Y + GS+A + + R YF
Sbjct: 66 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYF 110
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 32.3 bits (72), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L+V + G++++ L+ + ++ +K +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed
With Inhibitor Pd0407824
Length = 289
Score = 32.3 bits (72), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 9/105 (8%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEV-EMISLAV- 354
T+ F +G G FG+V+K + DG + A+KR K + G + Q + E+ + AV
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 67
Query: 355 --HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR--QYF 395
H +++R L+ Y + GS+A + + R YF
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYF 112
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 32.3 bits (72), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 16/48 (33%), Positives = 27/48 (56%), Gaps = 1/48 (2%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG 338
K+ ++ + + L+GKGGFG V+ G+ L D VA+K + +G
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLG 71
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 32.3 bits (72), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 21/82 (25%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+ +++ D G E+ ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 32.3 bits (72), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 21/82 (25%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
NF +G+G +G VYK + G VVA+ +++ D G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 357 NLLRLIGFCMTTTERLLVYPYM 378
N+++L+ T + LV+ ++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 32.3 bits (72), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L+V + G++++ L+ + ++ +K+
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 136
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 32.3 bits (72), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 25/84 (29%), Positives = 38/84 (45%), Gaps = 12/84 (14%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVE 348
ATS + +G G +G VYK G VA+K ++ N G E+ +E
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 349 MISLAVHRNLLRLIGFCMTT-TER 371
H N++RL+ C T+ T+R
Sbjct: 62 AFE---HPNVVRLMDVCATSRTDR 82
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 32.3 bits (72), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 25/84 (29%), Positives = 38/84 (45%), Gaps = 12/84 (14%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVE 348
ATS + +G G +G VYK G VA+K ++ N G E+ +E
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 349 MISLAVHRNLLRLIGFCMTT-TER 371
H N++RL+ C T+ T+R
Sbjct: 62 AFE---HPNVVRLMDVCATSRTDR 82
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 32.3 bits (72), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L+V + G++++ L+ + ++ +K+
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 138
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 32.3 bits (72), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L+V + G++++ L+ + ++ +K+
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131
>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770
Length = 285
Score = 32.3 bits (72), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 9/105 (8%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEV-EMISLAV- 354
T+ F +G G FG+V+K + DG + A+KR K + G + Q + E+ + AV
Sbjct: 6 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 63
Query: 355 --HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR--QYF 395
H +++R L+ Y + GS+A + + R YF
Sbjct: 64 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYF 108
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 32.3 bits (72), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L+V + G++++ L+ + ++ +K +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 32.3 bits (72), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 25/84 (29%), Positives = 38/84 (45%), Gaps = 12/84 (14%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVE 348
ATS + +G G +G VYK G VA+K ++ N G E+ +E
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 349 MISLAVHRNLLRLIGFCMTT-TER 371
H N++RL+ C T+ T+R
Sbjct: 62 AFE---HPNVVRLMDVCATSRTDR 82
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 32.3 bits (72), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 26/101 (25%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFIHKS 399
L+G C L+V + G++++ L+ + ++ +K
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKD 135
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 32.3 bits (72), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 34/113 (30%), Positives = 47/113 (41%), Gaps = 12/113 (10%)
Query: 295 QSATSNFSSKNL-----VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--QF 343
QS T K+L +G G FG V +G VAVK LK E F
Sbjct: 3 QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 344 QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
EV + HRNL+RL G +T + +V GS+ RL+ + + +
Sbjct: 63 IREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL 114
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 32.3 bits (72), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 26/100 (26%), Positives = 50/100 (50%), Gaps = 8/100 (8%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFIHK 398
L+G C L+V + G++++ L+ + ++ +K
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 32.3 bits (72), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFI 396
L+G C L+V + G++++ L+ SKR F+
Sbjct: 86 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFV 122
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 32.0 bits (71), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 360 RLIGFCMTTTERLLVY-PYMSNGSVASRLKGSKRQYFI 396
L+G C L+V + G++++ L+ SKR F+
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLR-SKRNEFV 122
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 32.0 bits (71), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 34/113 (30%), Positives = 47/113 (41%), Gaps = 12/113 (10%)
Query: 295 QSATSNFSSKNL-----VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--QF 343
QS T K+L +G G FG V +G VAVK LK E F
Sbjct: 3 QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 344 QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
EV + HRNL+RL G +T + +V GS+ RL+ + + +
Sbjct: 63 IREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL 114
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 32.0 bits (71), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 28 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L+V + G++++ L+ + ++ +K+
Sbjct: 88 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 129
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 32.0 bits (71), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 20/87 (22%), Positives = 38/87 (43%), Gaps = 1/87 (1%)
Query: 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
L+GKG FG VY G + + ++ N + F+ EV H N++ +G
Sbjct: 39 ELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLK-AFKREVMAYRQTRHENVVLFMGA 97
Query: 365 CMTTTERLLVYPYMSNGSVASRLKGSK 391
CM+ ++ ++ S ++ +K
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAK 124
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 32.0 bits (71), Expect = 0.58, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 360 RLIGFCMTTTERLLVY-PYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L+V + G++++ L+ + ++ +K +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 32.0 bits (71), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 17/89 (19%), Positives = 45/89 (50%), Gaps = 1/89 (1%)
Query: 305 NLVGK-GGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
++G+ G FG VYK ++ +V+A ++ D + + E+++++ H N+++L+
Sbjct: 15 EIIGELGDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 74
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKGSKR 392
++ + + G+V + + +R
Sbjct: 75 AFYYENNLWILIEFCAGGAVDAVMLELER 103
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 32.0 bits (71), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG VAVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 366 MTTTERLLVYPYMSNGS 382
+T +L + GS
Sbjct: 73 -STAPQLAIVTQWCEGS 88
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 32.0 bits (71), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFIHKSS 400
L+G C L+V + G++++ L+ + ++ +K +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 173
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 32.0 bits (71), Expect = 0.64, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 360 RLIGFCMTTTERLLVY-PYMSNGSVASRLKGSKRQYFI 396
L+G C L+V + G++++ L+ SKR F+
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLR-SKRNEFV 122
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 32.0 bits (71), Expect = 0.64, Method: Compositional matrix adjust.
Identities = 22/59 (37%), Positives = 31/59 (52%), Gaps = 2/59 (3%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
E + S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 1 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 59
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 32.0 bits (71), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG VAVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 21 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 366 MTTTERLLVYPYMSNGS 382
+T +L + GS
Sbjct: 78 -STKPQLAIVTQWCEGS 93
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 32.0 bits (71), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG VAVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 18 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 74
Query: 366 MTTTERLLVYPYMSNGS 382
+T +L + GS
Sbjct: 75 -STKPQLAIVTQWCEGS 90
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 32.0 bits (71), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 26/101 (25%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 307 VGKGGFGNVYKG--YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG V + + D T VAVK LK+G +E++ +I + H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 360 RLIGFCMTTTERLLV-YPYMSNGSVASRLKGSKRQYFIHKS 399
L+G C L+V + G++++ L+ + ++ +K
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKD 135
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 31.6 bits (70), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG VAVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 366 MTTTERLLVYPYMSNGS 382
+T +L + GS
Sbjct: 73 -STKPQLAIVTQWCEGS 88
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 31.6 bits (70), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG VAVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 366 MTTTERLLVYPYMSNGS 382
+T +L + GS
Sbjct: 73 -STKPQLAIVTQWCEGS 88
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 31.6 bits (70), Expect = 0.74, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG VAVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 21 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 366 MTTTERLLVYPYMSNGS 382
+T +L + GS
Sbjct: 78 -STKPQLAIVTQWCEGS 93
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 31.6 bits (70), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG VAVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 36 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 92
Query: 366 MTTTERLLVYPYMSNGS 382
+T +L + GS
Sbjct: 93 -STKPQLAIVTQWCEGS 108
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 31.6 bits (70), Expect = 0.81, Method: Compositional matrix adjust.
Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYL---QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+G G FG+V +G + VA+K LK G + E +++ + ++RLIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
C E L++ M+ G + KR+
Sbjct: 404 VC--QAEALMLVMEMAGGGPLHKFLVGKRE 431
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 31.6 bits (70), Expect = 0.83, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG VAVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 43 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 99
Query: 366 MTTTERLLVYPYMSNGS 382
+T +L + GS
Sbjct: 100 -STKPQLAIVTQWCEGS 115
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 31.6 bits (70), Expect = 0.87, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG VAVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 44 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 100
Query: 366 MTTTERLLVYPYMSNGS 382
+T +L + GS
Sbjct: 101 -STKPQLAIVTQWCEGS 116
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 31.6 bits (70), Expect = 0.90, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG VAVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 44 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 100
Query: 366 MTTTERLLVYPYMSNGS 382
+T +L + GS
Sbjct: 101 -STKPQLAIVTQWCEGS 116
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 31.2 bits (69), Expect = 0.93, Method: Compositional matrix adjust.
Identities = 22/90 (24%), Positives = 40/90 (44%), Gaps = 1/90 (1%)
Query: 303 SKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+ L+G+G + V LQ+G AVK ++ F+ + ++N+L L
Sbjct: 17 TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
I F T LV+ + GS+ + ++ K
Sbjct: 77 IEFFEDDTRFYLVFEKLQGGSILAHIQKQK 106
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 1/89 (1%)
Query: 301 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
F+ +GKG FG V+KG + VVA+K + A Q E+ ++S +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ G + T+ ++ Y+ GS L+
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLE 112
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 43/88 (48%), Gaps = 2/88 (2%)
Query: 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLL 359
++ +N +G+G +G V K +Q GT + K ++ +F+ E+E++ H N++
Sbjct: 11 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRL 387
RL T+ LV + G + R+
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERV 97
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 43/88 (48%), Gaps = 2/88 (2%)
Query: 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLL 359
++ +N +G+G +G V K +Q GT + K ++ +F+ E+E++ H N++
Sbjct: 28 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRL 387
RL T+ LV + G + R+
Sbjct: 87 RLYETFEDNTDIYLVMELCTGGELFERV 114
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 29/96 (30%), Positives = 41/96 (42%), Gaps = 7/96 (7%)
Query: 307 VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLR 360
+G G FG V +G VAVK LK E F EV + HRNL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
L G +T + +V GS+ RL+ + + +
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL 110
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 26/101 (25%), Positives = 45/101 (44%), Gaps = 7/101 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYL-----QDGTV-VAVKRLKDGNAIGGEIQFQTEVEMIS- 351
+N +G G FG V + +D + VAVK LK + +E++++S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR 392
L H N++ L+G C L++ Y G + + L+ R
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR 146
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 26/101 (25%), Positives = 45/101 (44%), Gaps = 7/101 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYL-----QDGTV-VAVKRLKDGNAIGGEIQFQTEVEMIS- 351
+N +G G FG V + +D + VAVK LK + +E++++S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSKR 392
L H N++ L+G C L++ Y G + + L+ R
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR 146
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 6/89 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ T VAVK +K G ++ E F E ++ H L++L +
Sbjct: 23 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVE-AFLAEANVMKTLQHDKLVKLHA-VV 79
Query: 367 TTTERLLVYPYMSNGSVASRLK---GSKR 392
T ++ +M+ GS+ LK GSK+
Sbjct: 80 TKEPIYIITEFMAKGSLLDFLKSDEGSKQ 108
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 29/96 (30%), Positives = 41/96 (42%), Gaps = 7/96 (7%)
Query: 307 VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLR 360
+G G FG V +G VAVK LK E F EV + HRNL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
L G +T + +V GS+ RL+ + + +
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL 110
>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex
pdb|3B2D|B Chain B, Crystal Structure Of Human Rp105MD-1 Complex
Length = 603
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 40/74 (54%), Gaps = 1/74 (1%)
Query: 118 LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177
L K+ +DLS+N T ++SHL+ + YL L NS+ P L +SQ + ++LS+N
Sbjct: 496 LGKMSHVDLSHNSLTCDSIDSLSHLKGI-YLNLAANSINIISPRLLPILSQQSTINLSHN 554
Query: 178 NLSGPVPSFHAKTF 191
L + H T+
Sbjct: 555 PLDCTCSNIHFLTW 568
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 21/53 (39%), Positives = 29/53 (54%), Gaps = 2/53 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 1/89 (1%)
Query: 301 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
F+ +GKG FG V+KG + VVA+K + A Q E+ ++S +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ G + T+ ++ Y+ GS L+
Sbjct: 69 KYYGSYLKDTKLWIIMEYLGGGSALDLLE 97
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 21/53 (39%), Positives = 29/53 (54%), Gaps = 2/53 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 1/89 (1%)
Query: 301 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
F+ +GKG FG V+KG + VVA+K + A Q E+ ++S +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ G + T+ ++ Y+ GS L+
Sbjct: 69 KYYGSYLKDTKLWIIMEYLGGGSALDLLE 97
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 30.8 bits (68), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 21/53 (39%), Positives = 29/53 (54%), Gaps = 2/53 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQFQTEVEM 349
S + L+G GGFG+VY G + D VA+K + KD + GE+ T V M
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 30.8 bits (68), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 1/89 (1%)
Query: 301 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
F+ +GKG FG V+KG + VVA+K + A Q E+ ++S +
Sbjct: 29 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLK 388
+ G + T+ ++ Y+ GS L+
Sbjct: 89 KYYGSYLKDTKLWIIMEYLGGGSALDLLE 117
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 29/96 (30%), Positives = 41/96 (42%), Gaps = 7/96 (7%)
Query: 307 VGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLR 360
+G G FG V +G VAVK LK E F EV + HRNL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKGSKRQYFI 396
L G +T + +V GS+ RL+ + + +
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL 110
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 6/89 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ T VAVK +K G+ F E ++ H L++L +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHA-VV 246
Query: 367 TTTERLLVYPYMSNGSVASRLK---GSKR 392
T ++ +M+ GS+ LK GSK+
Sbjct: 247 TKEPIYIITEFMAKGSLLDFLKSDEGSKQ 275
>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2VX3|B Chain B, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2VX3|C Chain C, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2VX3|D Chain D, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2WO6|A Chain A, Human Dual-Specificity Tyrosine-Phosphorylation-Regulated
Kinase 1a In Complex With A Consensus Substrate Peptide
pdb|2WO6|B Chain B, Human Dual-Specificity Tyrosine-Phosphorylation-Regulated
Kinase 1a In Complex With A Consensus Substrate Peptide
Length = 382
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 19/55 (34%), Positives = 29/55 (52%), Gaps = 3/55 (5%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 352
+ +L+GKG FG V K Y + + VA+K +K+ A Q Q EV ++ L
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN--QAQIEVRLLEL 106
>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41
pdb|4AZE|B Chain B, Human Dyrk1a In Complex With Leucettine L41
pdb|4AZE|C Chain C, Human Dyrk1a In Complex With Leucettine L41
Length = 382
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 19/55 (34%), Positives = 29/55 (52%), Gaps = 3/55 (5%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 352
+ +L+GKG FG V K Y + + VA+K +K+ A Q Q EV ++ L
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN--QAQIEVRLLEL 106
>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANQ|B Chain B, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANQ|C Chain C, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANQ|D Chain D, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANR|A Chain A, Human Dyrk1aHARMINE COMPLEX
pdb|3ANR|B Chain B, Human Dyrk1aHARMINE COMPLEX
pdb|3ANR|C Chain C, Human Dyrk1aHARMINE COMPLEX
pdb|3ANR|D Chain D, Human Dyrk1aHARMINE COMPLEX
Length = 368
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 19/55 (34%), Positives = 29/55 (52%), Gaps = 3/55 (5%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 352
+ +L+GKG FG V K Y + + VA+K +K+ A Q Q EV ++ L
Sbjct: 35 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN--QAQIEVRLLEL 87
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 6/89 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ T VAVK +K G+ F E ++ H L++L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHA-VV 252
Query: 367 TTTERLLVYPYMSNGSVASRLK---GSKR 392
T ++ +M+ GS+ LK GSK+
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQ 281
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 22/90 (24%), Positives = 40/90 (44%), Gaps = 1/90 (1%)
Query: 301 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
F+ +GKG FG V+KG + VVA+K + A Q E+ ++S +
Sbjct: 25 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKG 389
+ G + ++ ++ Y+ GS L+
Sbjct: 85 KYYGSYLKGSKLWIIMEYLGGGSALDLLRA 114
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 25/97 (25%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYL-----QDGTV-VAVKRLKDGNAIGGEIQFQTEVEMIS- 351
+N +G G FG V + +D + VAVK LK + +E++++S
Sbjct: 31 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
L H N++ L+G C L++ Y G + + L+
Sbjct: 91 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 127
>pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit
Length = 192
Score = 30.4 bits (67), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 20/69 (28%), Positives = 31/69 (44%)
Query: 116 GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLS 175
G+L L+ L+L N TG P+ +Q L+L N + + QL L+L
Sbjct: 51 GRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLY 110
Query: 176 YNNLSGPVP 184
N +S +P
Sbjct: 111 DNQISCVMP 119
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 30.4 bits (67), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 5/90 (5%)
Query: 307 VGKGGFGNVYKGYL---QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+G G FG+V +G + VA+K LK G + E +++ + ++RLIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKGSKRQ 393
C E L++ M+ G + KR+
Sbjct: 78 VC--QAEALMLVMEMAGGGPLHKFLVGKRE 105
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 30.0 bits (66), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 25/97 (25%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYL-----QDGTV-VAVKRLKDGNAIGGEIQFQTEVEMIS- 351
+N +G G FG V + +D + VAVK LK + +E++++S
Sbjct: 38 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
L H N++ L+G C L++ Y G + + L+
Sbjct: 98 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 134
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 30.0 bits (66), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 25/100 (25%), Positives = 45/100 (45%), Gaps = 7/100 (7%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYL-----QDGTV-VAVKRLKDGNAIGGEIQFQTEVEMIS- 351
+N +G G FG V + +D + VAVK LK + +E++++S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKGSK 391
L H N++ L+G C L++ Y G + + L+ +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKR 145
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 30.0 bits (66), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 15/65 (23%), Positives = 37/65 (56%), Gaps = 1/65 (1%)
Query: 298 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 356
+S+F K+L+G+G +G V + G +VA+K+++ + ++ E++++ H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 357 NLLRL 361
N++ +
Sbjct: 70 NIITI 74
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 30.0 bits (66), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 15/65 (23%), Positives = 37/65 (56%), Gaps = 1/65 (1%)
Query: 298 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 356
+S+F K+L+G+G +G V + G +VA+K+++ + ++ E++++ H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 357 NLLRL 361
N++ +
Sbjct: 70 NIITI 74
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 30.0 bits (66), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 15/65 (23%), Positives = 37/65 (56%), Gaps = 1/65 (1%)
Query: 298 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 356
+S+F K+L+G+G +G V + G +VA+K+++ + ++ E++++ H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 357 NLLRL 361
N++ +
Sbjct: 70 NIITI 74
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 29.6 bits (65), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 25/97 (25%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYL-----QDGTV-VAVKRLKDGNAIGGEIQFQTEVEMIS- 351
+N +G G FG V + +D + VAVK LK + +E++++S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388
L H N++ L+G C L++ Y G + + L+
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 142
>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor
Length = 285
Score = 29.6 bits (65), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 22/42 (52%)
Query: 112 PTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 153
P L +L+TL L N + ++ L LQYLRLN+N
Sbjct: 193 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 234
>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding
Domain Reveals A Convergent Recognition Scaffold
Mediating Inhibition Of Myelination
Length = 285
Score = 29.6 bits (65), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 22/42 (52%)
Query: 112 PTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 153
P L +L+TL L N + ++ L LQYLRLN+N
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte
Receptors A29
Length = 270
Score = 29.6 bits (65), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 22/70 (31%), Positives = 32/70 (45%), Gaps = 1/70 (1%)
Query: 111 IPTEIGK-LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQL 169
+P I K L L TL +++N L L LRL+ N L P ++++L
Sbjct: 76 LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKL 135
Query: 170 AFLDLSYNNL 179
+L L YN L
Sbjct: 136 TYLSLGYNEL 145
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 29.6 bits (65), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 26/87 (29%), Positives = 39/87 (44%), Gaps = 15/87 (17%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----------EIQFQT 345
ATS + +G G +G VYK G VA+K ++ N GG E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 346 EVEMISLAVHRNLLRLIGFCMTT-TER 371
+E H N++RL+ C T+ T+R
Sbjct: 67 RLEAFE---HPNVVRLMDVCATSRTDR 90
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 29.3 bits (64), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 21/76 (27%), Positives = 35/76 (46%), Gaps = 3/76 (3%)
Query: 307 VGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
+G+G + VYKG L D +VA+K ++ + G EV ++ H N++ L
Sbjct: 10 LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 365 CMTTTERLLVYPYMSN 380
T LV+ Y+
Sbjct: 69 IHTEKSLTLVFEYLDK 84
>pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex
Length = 562
Score = 29.3 bits (64), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 30/60 (50%), Gaps = 2/60 (3%)
Query: 124 LDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL--SNMSQLAFLDLSYNNLSG 181
L+ + N FT + S L+ LQ L L N L +L NMS L LD+S N+L+
Sbjct: 358 LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS 417
Score = 28.1 bits (61), Expect = 9.0, Method: Compositional matrix adjust.
Identities = 19/58 (32%), Positives = 28/58 (48%), Gaps = 1/58 (1%)
Query: 120 KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177
K+ LDL NN IP V+HL+ LQ L + +N L ++ L ++ L N
Sbjct: 451 KVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
>pdb|2O0A|A Chain A, The Structure Of The C-terminal Domain Of Vik1 Has A Motor
Domain Fold But Lacks A Nucleotide-binding Site
Length = 298
Score = 28.9 bits (63), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 38/88 (43%), Gaps = 18/88 (20%)
Query: 144 TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATG 203
TLQ++ L+++ SQ LD S+N+ F + ++ +I G
Sbjct: 129 TLQFVFLSDDEF-----------SQDMLLDYSHNDKDSIKLKFEKHSISLDSKLVIIENG 177
Query: 204 AEEDCFGTAPMPLSFALNNSPNSKPSGM 231
E+ +PL+F+ + PN SGM
Sbjct: 178 LED-------LPLNFSCDEHPNLPHSGM 198
>pdb|4ETP|B Chain B, C-Terminal Motor And Motor Homology Domain Of Kar3vik1
Fused To A Synthetic Heterodimeric Coiled Coil
Length = 333
Score = 28.9 bits (63), Expect = 4.8, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 38/88 (43%), Gaps = 18/88 (20%)
Query: 144 TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATG 203
TLQ++ L+++ SQ LD S+N+ F + ++ +I G
Sbjct: 164 TLQFVFLSDDEF-----------SQDMLLDYSHNDKDSIKLKFEKHSISLDSKLVIIENG 212
Query: 204 AEEDCFGTAPMPLSFALNNSPNSKPSGM 231
E+ +PL+F+ + PN SGM
Sbjct: 213 LED-------LPLNFSADEHPNLPHSGM 233
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 28.5 bits (62), Expect = 6.6, Method: Compositional matrix adjust.
Identities = 19/92 (20%), Positives = 44/92 (47%), Gaps = 5/92 (5%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQ----TEV 347
+++S + + +G+G F VYK ++ +VA+K++K G+ + E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 379
+++ H N++ L+ + LV+ +M
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFME 95
>pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein
pdb|2FT3|B Chain B, Crystal Structure Of The Biglycan Dimer Core Protein
pdb|2FT3|C Chain C, Crystal Structure Of The Biglycan Dimer Core Protein
pdb|2FT3|D Chain D, Crystal Structure Of The Biglycan Dimer Core Protein
pdb|2FT3|E Chain E, Crystal Structure Of The Biglycan Dimer Core Protein
pdb|2FT3|F Chain F, Crystal Structure Of The Biglycan Dimer Core Protein
Length = 332
Score = 28.5 bits (62), Expect = 7.3, Method: Compositional matrix adjust.
Identities = 21/67 (31%), Positives = 36/67 (53%), Gaps = 1/67 (1%)
Query: 114 EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLD 173
++ + SKL L L +N ++S L TL+ L L+NN L+ +P L ++ L +
Sbjct: 212 DLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270
Query: 174 LSYNNLS 180
L NN++
Sbjct: 271 LHTNNIT 277
>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex
Length = 466
Score = 28.5 bits (62), Expect = 7.7, Method: Compositional matrix adjust.
Identities = 26/71 (36%), Positives = 35/71 (49%), Gaps = 6/71 (8%)
Query: 118 LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177
L+KL L L N + P ++ L L L LN N L P +SN+ L +L L +N
Sbjct: 263 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 318
Query: 178 NLS--GPVPSF 186
N+S PV S
Sbjct: 319 NISDISPVSSL 329
>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex
Length = 461
Score = 28.5 bits (62), Expect = 7.8, Method: Compositional matrix adjust.
Identities = 26/71 (36%), Positives = 35/71 (49%), Gaps = 6/71 (8%)
Query: 118 LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177
L+KL L L N + P ++ L L L LN N L P +SN+ L +L L +N
Sbjct: 259 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 314
Query: 178 NLS--GPVPSF 186
N+S PV S
Sbjct: 315 NISDISPVSSL 325
>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human)
Recognition Complex
pdb|1O6T|A Chain A, Internalin (Inla,Listeria Monocytogenes) - Functional
Domain, Uncomplexed
pdb|1O6V|A Chain A, Internalin (Inla,Listeria Monocytogenes) - Functional
Domain, Uncomplexed
pdb|1O6V|B Chain B, Internalin (Inla,Listeria Monocytogenes) - Functional
Domain, Uncomplexed
Length = 466
Score = 28.1 bits (61), Expect = 8.0, Method: Compositional matrix adjust.
Identities = 26/71 (36%), Positives = 35/71 (49%), Gaps = 6/71 (8%)
Query: 118 LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177
L+KL L L N + P ++ L L L LN N L P +SN+ L +L L +N
Sbjct: 264 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 319
Query: 178 NLS--GPVPSF 186
N+S PV S
Sbjct: 320 NISDISPVSSL 330
>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex
pdb|2OMW|A Chain A, Crystal Structure Of Inla S192n Y369s/mec1 Complex
Length = 461
Score = 28.1 bits (61), Expect = 8.1, Method: Compositional matrix adjust.
Identities = 26/71 (36%), Positives = 35/71 (49%), Gaps = 6/71 (8%)
Query: 118 LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177
L+KL L L N + P ++ L L L LN N L P +SN+ L +L L +N
Sbjct: 259 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 314
Query: 178 NLS--GPVPSF 186
N+S PV S
Sbjct: 315 NISDISPVSSL 325
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 28.1 bits (61), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 17/75 (22%), Positives = 35/75 (46%), Gaps = 1/75 (1%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+G+G +G VYK G A+K+++ + G E+ ++ H N+++L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 366 MTTTERLLVYPYMSN 380
T +LV+ ++
Sbjct: 70 HTKKRLVLVFEHLDQ 84
>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex
Length = 462
Score = 28.1 bits (61), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 26/71 (36%), Positives = 35/71 (49%), Gaps = 6/71 (8%)
Query: 118 LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177
L+KL L L N + P ++ L L L LN N L P +SN+ L +L L +N
Sbjct: 260 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 315
Query: 178 NLS--GPVPSF 186
N+S PV S
Sbjct: 316 NISDISPVSSL 326
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 28.1 bits (61), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 17/75 (22%), Positives = 35/75 (46%), Gaps = 1/75 (1%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+G+G +G VYK G A+K+++ + G E+ ++ H N+++L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 366 MTTTERLLVYPYMSN 380
T +LV+ ++
Sbjct: 70 HTKKRLVLVFEHLDQ 84
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 28.1 bits (61), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 17/75 (22%), Positives = 35/75 (46%), Gaps = 1/75 (1%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+G+G +G VYK G A+K+++ + G E+ ++ H N+++L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 366 MTTTERLLVYPYMSN 380
T +LV+ ++
Sbjct: 70 HTKKRLVLVFEHLDQ 84
>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX
Length = 462
Score = 28.1 bits (61), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 26/71 (36%), Positives = 35/71 (49%), Gaps = 6/71 (8%)
Query: 118 LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177
L+KL L L N + P ++ L L L LN N L P +SN+ L +L L +N
Sbjct: 260 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 315
Query: 178 NLS--GPVPSF 186
N+S PV S
Sbjct: 316 NISDISPVSSL 326
>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX
Length = 462
Score = 28.1 bits (61), Expect = 8.7, Method: Compositional matrix adjust.
Identities = 26/71 (36%), Positives = 35/71 (49%), Gaps = 6/71 (8%)
Query: 118 LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177
L+KL L L N + P ++ L L L LN N L P +SN+ L +L L +N
Sbjct: 260 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 315
Query: 178 NLS--GPVPSF 186
N+S PV S
Sbjct: 316 NISDISPVSSL 326
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.134 0.408
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 10,823,313
Number of Sequences: 62578
Number of extensions: 411720
Number of successful extensions: 1709
Number of sequences better than 100.0: 565
Number of HSP's better than 100.0 without gapping: 239
Number of HSP's successfully gapped in prelim test: 326
Number of HSP's that attempted gapping in prelim test: 1135
Number of HSP's gapped (non-prelim): 675
length of query: 400
length of database: 14,973,337
effective HSP length: 101
effective length of query: 299
effective length of database: 8,652,959
effective search space: 2587234741
effective search space used: 2587234741
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 52 (24.6 bits)